Skip to main content
PLOS Biology logoLink to PLOS Biology
. 2025 Apr 22;23(4):e3003121. doi: 10.1371/journal.pbio.3003121

Werner syndrome exonuclease promotes gut regeneration and causes age-associated gut hyperplasia in Drosophila

Kun Wu 1,#, Juanyu Zhou 1,#, Yiming Tang 1,#, Qiaoqiao Zhang 1,#, Lishou Xiong 2,#, Xiaorong Li 3, Zhangpeng Zhuo 4, Mei Luo 2, Yu Yuan 1, Xingzhu Liu 1, Zhendong Zhong 4, XiaoXin Guo 1, Zihua Yu 1, Xiao Sheng 1, Guanzheng Luo 4, Haiyang Chen 1,*
Editor: Alex P Gould5
PMCID: PMC12013949  PMID: 40261911

Abstract

Human Werner syndrome (adult progeria, a well-established model of human aging) is caused by mutations in the Werner syndrome (WRN) gene. However, the expression patterns and functions of WRN in natural aging remain poorly understood. Despite the link between WRN deficiencies and progeria, our analyses of human colon tissues, mouse crypts, and Drosophila midguts revealed that WRN expression does not decrease but rather increases in intestinal stem cells (ISCs) with aging. Mechanistically, we found that the Drosophila WRN homologue (WRNexo) binds to Heat shock 70-kDa protein cognate 3 (Hsc70-3/Bip) to regulate the unfolded protein response of the endoplasmic reticulum (UPRER). Activation of the WRNexo-mediated UPRER in ISCs is required for ISC proliferation during injury repair. However, persistent DNA damage during aging leads to chronic upregulation of WRNexo in ISCs, where excessive WRNexo-induced ER stress drives age-associated gut hyperplasia in Drosophila. This study reveals how elevated WRNexo contributes to stem cell aging, providing new insights into organ aging and the pathogenesis of age-related diseases, such as colon cancer.


Mutations in the Werner syndrome (WRN) gene cause premature aging during early adulthood, but the role of this exonuclease in natural aging remains unclear. This study shows that the Drosophila homolog WRNexo regulates the unfolded protein response of the endoplasmic reticulum in intestinal stem cells, promoting gut regeneration during injury, but also triggers gut hyperplasia during aging.

Introduction

Human progeria syndromes are progressive disorders that lead to the appearance of unusually accelerated aging and a shortened life span. Werner syndrome, characterized by accelerated aging after puberty, is a representative type of progeria. This disease is caused by mutations in the WRN gene, which encodes the WRN protein with both exonuclease and RecQ helicase activities [1]. In patients with Werner syndrome, mutations have been identified in both the exonuclease and helicase domains [13]. Individuals with Werner syndrome die prematurely and exhibit age-related degenerative disorders, including skin ulcers, cataracts, atherosclerosis, diabetes, osteoporosis, subcutaneous fat loss, and cancers, early in life [4]. Studies of cultured cells from patients with Werner syndrome and in animal models harboring WRN mutations have shown that WRN plays roles in DNA replication, DNA damage repair, transcription, and recombination as well as telomere maintenance [1,5,6]. Despite extensive studies of the link between WRN and progeria phenotypes, its physiological function in natural aging remains largely unexplored.

By studying colonic and gastric cancer cells, two recent studies have shown that WRN is upregulated in cancers with microsatellite instability (MSI) and is essential for survival in these cancers [7,8]. However, the physiological function of WRN in normal gut homeostasis and age-associated gastrointestinal tumorigenesis has yet to be explored. The progressive loss of proliferative balance is a widely known hallmark of intestinal epithelium aging, leading to age-associated diseases, such as colorectal cancers [9,10]. The long-term homeostasis of the human intestinal epithelium relies on intestinal stem cells (ISCs), which are long-lived and possess unlimited potential to replicate and replenish old or damaged epithelial cells. Thus, a better understanding of WRN function in ISCs could provide insight into the physiology of gut homeostasis and aging.

The Drosophila adult midgut is a well-established system to study stem cell biology in tissue homeostasis, regeneration, and aging. Similar to the human intestine, the Drosophila midgut epithelium is sustained by resident ISCs that are long-lived due to their capacity for self-renewal [1114]. Drosophila ISCs (specifically expressing the Notch ligand Delta) are scattered along the basement membrane of the midgut epithelium, where they divide to self-renew and produce non-dividing enteroblasts (EBs, which further differentiate into absorptive enterocytes (ECs)) or enteroendocrine mother cells (which further differentiate into secretory enteroendocrine cells (EEs)) [11,12,1518] (S1A Fig). Under normal homeostatic conditions, most ISCs are in a quiescent state and divide slowly. In response to gut epithelium damage, these ISCs are rapidly activated with transiently increased proliferation rate to initiate EC and EE production. This regeneration process is regulated by multiple stress and mitogenic signaling pathways, such as epidermal growth factor receptor [19,20], c-Jun N-terminal kinase (JNK) [21], Janus kinase-signal transducer and activators of transcription [22,23], insulin [2426], Hippo [27], Wingless [28,29], and bone morphogenetic protein signaling pathways [30].

During aging, Drosophila develops epithelial hyperplasia in midguts that results from uncontrolled ISC over-proliferation and deficient EB differentiation [21,31]. This age-associated hyperplasia is associated with the chronic activation of diverse stress signaling mechanisms, including inflammatory conditions, metabolic changes, oxidative stress, and endoplasmic reticulum (ER) stress [3235]. The unfolded protein response of the endoplasmic reticulum (UPRER) which adjusts the protein folding capacity in response to stress, has emerged as a central regulator of Drosophila midgut epithelial homeostasis during regeneration and aging [36,37]. And excessive ER stress, in coordination with oxidative stress and JNK signaling, drives ISC hyper-proliferation in aging flies [36]. Although it has been linked to age-associated gut hyperplasia in old Drosophila, the underlying causes of the chronic UPRER activation during aging remain poorly understood.

Unlike human WRN, which has both exonuclease and helicase activities, Drosophila WRN possesses only exonuclease activity and is therefore named Werner syndrome exonuclease (WRNexo). WRNexo shares 35% identity and 59% similarity with the exonuclease domain of human WRN [38]. Similar to WRN-deficient human cells, Drosophila WRNexo-null mutants exhibit heightened DNA damage and increased sensitivity to DNA replication stress [3842].

Using the Drosophila midgut as a model system, we discovered that age-associated genomic instability induces WRNexo upregulation in ISCs. Elevated WRNexo exacerbates ER stress in ISCs by physically interacting with a UPRER sensor, Heat shock 70-kDa protein cognate 3 (Hsc70-3/Bip) [43,44], and suppressing its activation. Increased ER stress drives ISC hyperplasia through reactive oxygen species (ROS) and JNK signaling. Furthermore, our study demonstrates that the age-associated upregulation of WRNexo is directly triggered by elevated genomic instability in aged Drosophila ISCs. Our findings underscore the critical role of WRN in maintaining gut epithelial homeostasis, regulating natural aging, and involving age-associated hyperplasia in mammals.

Results

WRN is highly expressed in intestinal stem cells and upregulated upon natural aging

To investigate the functions of WRN in the human gut during natural aging, we analyzed normal colon tissues from both young and old individuals. Given that WRN mutations cause Werner syndrome—a condition characterized by premature aging—we anticipated that WRN expression would decrease with age. However, immunofluorescence microscopy revealed that, contrary to our prediction, WRN expression actually increased dramatically in the colon crypts of elderly individuals (Fig 1A1C). Western blotting and real-time quantitative PCR (RT-qPCR) analyses confirmed that WRN protein and mRNA expression levels were higher in the colon tissue from elderly individuals compared to young individuals (Fig 1D1F). Recent studies have shown that WRN expression is upregulated in cultured colonic and gastric cancer cell lines, promoting survival in colorectal cancers [7,8]. Since colon carcinoma is an age-associated disease, we further analyzed WRN expression in human colon carcinoma. Immunofluorescence microscopy revealed significantly higher WRN expression in the crypts of colorectal cancer regions compared to adjacent normal tissues (Fig 1G1I). RT-qPCR analyses confirmed that WRN expression was elevated in colon carcinoma tissues (Fig 1J). Additionally, we analyzed WRN expression in aged mice. Both western blotting and RT-qPCR analyses demonstrated elevated WRN expression in the crypts of aged mice (Fig 1K1M). These findings suggest that the increased WRN expression observed in elderly colon tissues and cancerous tissues reflects distinct functional roles of WRN in natural tissue aging and in premature aging associated with Werner syndrome, which is characterized by a WRN deficiency.

Fig 1. WRN is highly expressed in intestinal stem cells and upregulated upon natural aging.

Fig 1

(A, B) Immunofluorescence staining of WRN in human para-carcinoma colon tissues from young (the mean age was 29 years, n = 4) (A) and old individuals (the mean age was 67 years, n = 7) (B). WRN was detected using a specific antibody (red). Boxed areas in (A, B) are enlarged to the right. (C) Quantification of WRN fluorescence intensity in the boxed regions of crypts from panels (A, B). Colon samples were obtained from four young patients and seven old patients. Each dot represents one cell. (D) Western blotting results indicate an increase in WRN expression in colons with aging. Loading controls, α-Tubulin. Colon samples were from four young patients and seven old patients. (E) Quantification of WRN band intensity from experiments shown in panel (D). (F) Relative mRNA fold changes of WRN in normal young and old para-carcinoma colons. Data are normalized to young colons (control, set to 1). Error bars indicate the standard deviation (SD) from three independent experiments. (G, H) Representative images of WRN staining in human colons. Normal para-carcinoma colons (as control, G) and carcinoma colons from patients with colon cancer (H). Cells were stained by WRN (red). The boxed areas in (G, H) are enlarged to the right. (I) Quantification of WRN fluorescence intensity in experiments (G, H). Each dot represents one cell in boxed regions of crypts. (J) Relative mRNA fold changes of WRN in para-carcinoma colons and carcinoma colons. Data are normalized to para-carcinoma colons (control, set to 1). Error bars indicate the standard deviation (SD) from three independent experiments. (K) Western blotting showing WRN expression levels in crypts from young and old mouse colons. Loading controls, α-Tubulin. (L) Quantification of WRN band intensity from experiments shown in panel (K). (M) Relative mRNA fold changes of WRN in young and old mouse crypts. Data are normalized to young crypts (control, set to 1). Error bars indicate the standard deviation (SD) from three independent experiments. (N, O) Representative images of WRNexo-mCherry expression in young (N) and old (O) Drosophila midguts. (P) Quantification of mCherry fluorescence intensity per cell from experiments (N, O); each dot represents one WRNexo-mCherry+ cell. (Q) Relative mRNA fold changes of WRNexo in young and old Drosophila midguts. Data are normalized to young midguts (control, set to 1). Error bars indicate the standard deviation (SD) from three independent experiments. (R–U) Immunofluorescence images of WRNexo-mCherry expression in young (7-day-old) Drosophila posterior midguts. WRNexo-mCherry was detected in esg-GFP+ cells (R), Dl+ ISCs (white arrow) (S), and NRE+ EBs (white arrow) (T) but not in Pros+ EEs (white arrow) (U). Dashed lines indicate only WRNexo-mCherry-positive cells (S and T). Dashed lines indicate ECs (R). (V–Y) Immunofluorescence images of WRNexo-mCherry in posterior midguts of aged (40-day-old) Drosophila. WRNexo-mCherry expression increased in esg-GFP+ cells (V), Dl+ ISCs (white arrow) (W), NRE+ EBs (white arrow) (X), and some Pros+ EEs (white arrow) (Y). Dashed lines indicate only WRNexo-mCherry-positive cells (W and X). (Z, A′, B′) Quantification of mCherry fluorescence intensity in esg-GFP+ (Z), Dl+ (A′), and NRE+ (B′) cells from young and aged posterior midguts. Each dot represents one cell. DAPI-stained nuclei (blue). Scale bars represent 50 μm in A, B, and G, H, 25 μm in N and O, 5 μm in R to U and V to Y. Error bars represent SD. Student t tests, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, and NS (non-significant) represents p > 0.05. See also S1 Fig and S3 Table. Underlying data and statistical analysis in S1 Data.

Given the elevated expression of WRN in intestinal crypts of elderly individuals and mice, we further investigated whether WRN plays a role in gut homeostasis and natural aging using the Drosophila midgut system [11,12,45]. Drosophila WRNexo (CG7670) has been identified as an ortholog of human WRN exonuclease for modeling Werner syndrome [38,46]. To trace endogenous WRNexo expression during gut homeostasis and aging in Drosophila, we generated the WRNexo-mCherry reporter line using the CRISPR/Cas9 knock-in system (S1B Fig). Although expressed throughout the midgut, WRNexo was more highly expressed in the posterior region (R4–R5) compared to the anterior region (R1–R3) (S1C and S1D Fig). Consistent with observations in human intestines, WRNexo expression levels in the midguts of aged Drosophila were significantly higher than those in young flies (Figs 1N1P and S1C and S1D). RT-qPCR analyses revealed that the elevation of WRNexo expression in the midguts of aged flies might be explained by an increase in transcription (Fig 1Q). Analysis of previously published RNA-sequencing (RNA-seq) data from whole guts from young and old flies [47], yielded similar results, showing elevated WRNexo expression in aged guts (S1E and S1F Fig).

Importantly, we found that WRNexo was not ubiquitously expressed in the Drosophila intestinal epithelium but was specifically expressed in cells with a relatively small nucleus. By co-staining with cell type-specific markers, in the posterior midguts, we found that WRNexo expression in the intestinal epithelium of young Drosophila was restricted to Delta+ (Dl+) ISCs and NRE+ EBs (both ISCs and EBs are esg-GFP+, Fig 1R1T). WRNexo expression was almost undetectable in terminally differentiated ECs (esg-negative cells with a polyploid nucleus; Fig 1R) and Prospero+ (Pros+) EEs (Fig 1U). Furthermore, WRNexo expression was significantly higher in the ISCs and EBs of aged flies (Fig 1V1X and 1Z1B′) compared to young flies (Fig 1R1T and 1Z1B′). In the midguts of aged flies, WRNexo was expressed in a subset of Pros+ EEs (Fig 1Y), which may result from the accumulation of esg+ premature EEs in aged midguts [16,17,21]. Additionally, in the anterior midguts, the expression pattern of WRNexo was similar to that observed in the posterior midguts (S1GS1J Fig). These data suggest that WRNexo may function in intestinal stem and progenitor cells in Drosophila. Beyond the intestines, WRNexo was found to be highly expressed in female and male germline stem and progenitor cells in Drosophila (S1K and S1L Fig).

WRNexo is essential for the maintenance of gut homeostasis and the activation of ISC proliferation after injury

To study the physiological function of WRNexo in tissue homeostasis and natural aging, we generated WRNexo mutant Drosophila lines using the CRISPR/Cas9 knock-out system (S2A Fig). We obtained three alleles (WRNexo10, WRNexo12, and WRNexo15) carrying deletions in WRNexo exon 1 or exon 2 (S2A Fig). Since the coding region of WRNexo is almost entirely disrupted in these alleles, they can be regarded as null alleles. WRNexo-null (WRNexo10/12 and WRNexo10/15 transheterozygotes) mutant flies were viable. The overall morphology of midguts (Figs 2A, and S2BS2E) and the proliferation rate of ISCs, as indicated by immunostaining for pH3 (a marker of ISC proliferation) and esg-GFP (a marker indicating the total number of ISCs and EBs), were largely similar in young (7 days old) WRNexo-null mutant flies and wild-type flies (S2FS2J Fig). However, in the midguts of 40-day-old WRNexo-null flies (Fig 2C), epithelial cells were more sparsely distributed compared to those in wild-type controls (Fig 2B and 2C). The midgut length was significantly shorter in aged WRNexo-null flies (40 days old) compared to wild-type flies of the same age (Fig 2A, 2D, and 2E). Additionally, while the numbers of pH3+ cells and esg-GFP+ cells increased in the midguts of old wild-type flies due to the accumulation of ISCs and EBs [21,35,48], these counts remained low in WRNexo-null flies (Fig 2F2I). In addition, we found that WRNexo-null flies showed a significantly shorter life span than that of wild-type flies (Fig 2J). These data indicate that the WRNexo depletion disrupts gut homeostasis during aging in Drosophila, as evidenced by shortened gut length, impaired ISC proliferation, compromised epithelial integrity, and reduced life span.

Fig 2. WRNexo is essential for maintaining gut homeostasis and for activating ISC proliferation after injury.

Fig 2

(A) Mean length of young and old midguts from flies with indicated genotypes. Lengths were measured from images of DAPI-stained guts, spanning from the midline of the proventriculus to the midgut–hindgut boundary. n is as indicated. (B, C) Representative images of DAPI and Armadillo staining in midguts from 40-day-old flies. Epithelial cells in the WRNexo-null midguts (C) were sparsely distributed compared to those in wild-type flies (B). (D, E) DAPI-stained whole midgut images. WRNexo-null midguts (E) were significantly shorter than wild-type midguts (D) in 40-day-old flies. (F, G) Immunofluorescence images of esg-GFP midguts in aged (40 days) control (esg-GFP/+, F) and WRNexo-null flies (esg-GFP/+; WRNexo10/WRNexo12, G). (H) Quantification of the pH3+ cells in 40-day-old midguts from control flies (esg-GFP/+) and WRNexo-null flies (esg-GFP/+; WRNexo10/WRNexo12 and esg-GFP/+; WRNexo10/WRNexo15). Each dot represents one midgut, n is as indicated. (I) Quantification of esg-GFP+ cells in a 10,000 μm2 area of midguts with indicated genotypes from experiments (F, G). Each dot represents a region of interest (ROI) (region of interest). ROI size was 10,000 μm2, n is as indicated. (J) Survival rate of WRNexo-null flies raised on normal food and temperature conditions. WT (W1118) flies served as controls. (K, L) Immunofluorescence images of WRNexo-mCherry reporter midguts treated with 5% sucrose (K) or paraquat (PQ) for 1 day, followed by a 1-day recovery on normal food (hereafter referred as PQ-REC-1D) (L). (M) Quantification of mCherry fluorescence intensity in midguts from flies treated with 5% sucrose (K) or PQ-REC-1D (L). (N–P) Immunofluorescence images of esg-GFP midguts from control flies under normal conditions (N), PQ-REC-1D-treated control (O), and WRNexo-null (P) flies. (Q) Quantification of pH3+ cells in whole midguts from the experiment (N–P). Each dot represents one midgut, n is as indicated. (R) Quantification of esg-GFP+ cell numbers in a 10,000 μm2 area of midguts with indicated genotypes from experiments (N–P). Each dot represents a ROI. ROI size was 10,000 μm2, n is as indicated. (S) WRNexo-mCherry expression during bleomycin (BLM)-induced regeneration. Flies were cultured under normal conditions (BLM-0D), exposed to BLM for one day (BLM-1D), or recovered on regular food for 1–3 days (BLM-REC-1D to BLM-REC-3D). (T) Line graphs depicting trends in mCherry fluorescence intensity (red line) and pH3+ cell counts (green line) during BLM-induced regeneration. n is as indicated. (U–W) Immunofluorescence images of FRT82B control (U), WRNexo-null (V), and WRNexo-null with WRNexo overexpression (W) in MARCM clones 10 days after clone induction (ACI). (X) Quantification of MARCM clone size in FRT82B control, WRNexo-null, and WRNexo-null with WRNexo overexpressing MARCM clones 10 days ACI. Each dot represents a clone, n is as indicated. (Y) Immunofluorescence images of midguts carrying ISCts (esg-GAL4, UAS-GFP; tub-Gal80ts, NRE-Gal80) (Control) and WRNexo cDNA overexpression vectors. The midguts were stained with GFP and Delta. Delta and DAPI channel images are shown in the lower panel. (Z) Immunofluorescence images of midguts carrying NREts (NRE-GAL4, UAS-GFP, tub-Gal80ts) (Control) and WRNexo cDNA overexpression vectors. The midguts were stained with GFP and Delta. The Delta and DAPI channel images are shown in the lower panel. (A′) Quantification of Delta+ cells per ROI (10,000 µm²) in midguts from experiments in (Y, Z). Each dot represents a ROI. The ROI size was 10,000 μm2, n is as indicated. DAPI-stained nuclei (blue). Scale bars represent 5 μm in S, 10 μm in B, C, U–W, Y, and Z, 25 μm in F, G, K, L, and N–P, 200 μm in D and E. Error bars represent SD. Student t tests, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, and NS (non-significant) represents p > 0.05. See also S2 Fig and S3 Table. Underlying data and statistical analysis in S2 Data.

The accumulation of damage in response to diverse environmental stimuli is thought to contribute to the aging process in animals [35]. In adult Drosophila, resident ISCs in the midgut play a crucial role in maintaining gut homeostasis by replenishing damaged epithelial cells and promoting tissue repair after injury [49]. This regenerative response is essential for sustaining intestinal homeostasis. To study ISC behavior under stress, researchers commonly employ various stressors, such as paraquat (PQ) or bleomycin (BLM), in the Drosophila midgut [49,50]. Interestingly, we found that WRNexo protein expression increased significantly in the midguts of Drosophila after PQ-induced injury (Fig 2K2M), suggesting that WRNexo may play a role in the cellular response to injury. Consistent with our hypothesis, we observed that the pH3+ and esg-GFP+ cell counts in wild-type midguts increased rapidly along the epithelium to repair PQ-induced intestinal damage [21,34] (Fig 2N, 2O, 2Q, and 2R). However, in the WRNexo-null midguts, the numbers of pH3+ cells and esg-GFP+ cells does not increase after injury (Fig 2P2R), indicating impaired ISC proliferation in WRNexo-depleted Drosophila. Furthermore, both WRNexo expression and ISC proliferation (as indicated by the presence of pH3+ cells) followed a similar pattern during the midgut regeneration induced by BLM. Initially, WRNexo expression and ISC proliferation increased, followed by a gradual decrease (Fig 2S and 2T). These findings suggest that the upregulation of WRNexo during midgut regeneration is crucial for the activation of ISC proliferation.

To further demonstrate that WRNexo is essential for the activation of ISC proliferation, we analyzed WRNexo-null clones using a mosaic analysis with a repressible cell marker (MARCM), which labels all progeny of a single active ISC with a visible GFP marker. Consistently, WRNexo-null clones were much smaller than wild-type clones (Fig 2U, 2V, and 2X). Importantly, the ISC proliferation defect observed in the WRNexo-null clones could be fully reversed by expressing WRNexo cDNA (Fig 2W and 2X). In addition, esg-Gal4-driven Flip-out (F/O) lineage tracing combined with RNAi showed that the depletion of WRNexo led to the ISC proliferation defect (S2KS2N Fig). Two WRNexo RNAi lines showed significantly lower WRNexo expression levels compared to wild-type controls (S2O Fig). To further investigate the role of WRNexo in ISCs or EBs for regulating ISC proliferation, we overexpressed WRNexo using ISCts (esg-GAL4, UAS-GFP; tub-Gal80ts, NRE-Gal80) or NREts(NRE-GAL4, UAS-GFP, tub-Gal80ts) drivers [51], respectively. We found that WRNexo overexpression in ISCs, but not in EBs, significantly increased the ISC proliferation rate, as indicated by Dl staining (Fig 2Y2A′). Altogether, these data indicated that WRNexo is essential for the activation of ISC proliferation.

WRNexo functions cell-autonomously in ISCs to promote ISC proliferation

The endogenous WRNexo reporter line WRNexo-mCherry indicated that WRNexo is specifically expressed in ISCs and EBs of young Drosophila (Fig 1R1U). To investigate whether WRNexo functions cell-autonomously in ISCs and EBs or non-cell-autonomously in other intestinal cells to promote ISC proliferation, we used cell type-specific RNAi knockdown of WRNexo. We found that WRNexo depletion specifically in ISCs but not in EBs, ECs, EEs, muscle cells, or tracheal cells led to ISC proliferation defects. These defects were comparable to those observed in WRNexo-null midguts after injury. This was evident from the absence of increases in pH3+ mitotic cells (Fig 3A and 3B) and esg+ cells (Fig 3C3P) in injured or aged midguts.

Fig 3. WRNexo functions cell-autonomously in ISCs to promote ISC proliferation.

Fig 3.

(A) Quantification of pH3+ cells in PQ-REC-1D-treated midguts with control (type-specific Gal4 lines only) and WRNexo-depleted flies using type-specific GAL4-driven RNAi, as indicated. n represents the number of midguts analyzed. (B) Quantification of pH3+ cells in aged (40 days) midguts from control (type-specific Gal4 lines only) and WRNexo-depleted flies using type-specific GAL4-driven RNAi, as indicated. n represents the number of midguts analyzed. (C) Quantification of esg-GFP+ cells in PQ-REC-1D midguts with control (type-specific Gal4 lines only) and WRNexo depleted by different cell type-specific GAL4-driven RNAi, as indicated. ROI size was 10,000 μm2, n is as indicated. (D) Quantification of esg-GFP+ cells of aged (40 days) midguts with control (type-specific Gal4 lines only) and WRNexo depleted by different cell type-specific GAL4-driven RNAi as indicated. ROI size was 10,000 μm2, n is as indicated. (E, F) Immunofluorescence images of PQ-REC-1D-treated midguts from flies carrying esgts-GAL4-driven UAS-GFP (E, control) or WRNexo RNAi (F). (G, H) Immunofluorescence images of aged midguts from flies carrying esgts-GAL4-driven UAS-GFP (G, control) or WRNexo RNAi (H). (I, J) ISC-specific GAL4-UAS system (ISCts) in control (ISCts-GAL4-driven UAS-GFP) (I) and WRNexo RNAi flies (J) following PQ-REC-1D treatment. (K, L) Immunofluorescence images of aged midguts from flies carrying ISCts-GAL4-driven UAS-GFP (K, control) and WRNexo RNAi flies (L). (M, N) EB-specific GAL4-UAS system (NREts) in control (NREts-GAL4-driven UAS-GFP) (M) and WRNexo RNAi flies (N) following PQ-REC-1D treatment. (O, P) Immunofluorescence images of aged midguts from NREts-GAL4-driven UAS-GFP (O, control) and WRNexo RNAi flies (P). (Q–S) Immunofluorescence images of midguts stained for Delta in UAS-LacZ (Q, control), WRNexo-null (R), and combined WRNexo-overexpressing with WRNexo-null (S) flies following PQ-REC-1D treatment. Single-channel images of midguts with Delta immunostaining are shown in the lower panels. (T) Quantification of pH3+ cells and Delta+ cells per ROI for midguts of experiments in (Q–S). n is as indicated. DAPI-stained nuclei (blue). Scale bars represent 25 μm in E–P and 5 μm in Q–S. Error bars represent SD. Student t tests, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, and NS (non-significant) represents p > 0.05. See also S3 Table. Underlying data and statistical analysis in S3 Data.

Importantly, expression of WRNexo cDNA using the esg-Gal4 driver fully restored ISC proliferation in WRNexo-null midguts after injury (Figs 3Q3T, and S3AS3C). These results demonstrate that WRNexo functions cell-autonomously in ISCs to promote ISC proliferation, ensuring normal gut epithelial homeostasis and regeneration following injury.

WRNexo regulates ISC proliferation by regulating the activation of UPRER

Since the WRNexo-null midguts failed to exhibit ISC proliferation after injury, we aimed to identify the mechanism by which WRNexo promotes ISC proliferation during Drosophila midgut regeneration, RNA-seq was performed on dissected midguts from WRNexo-null and wild-type flies before and after BLM-induced injury (see S1 and S2 Tables).

RNA-seq analyses revealed that genes involved in proteostasis, including Hsp67Ba, Hsp67Bc, Hsp68, and Hsp70 family genes, were significantly upregulated in WRNexo-null midguts compared to wild-type midguts following BLM-induced injury (Fig 4A and S2 Table). However, no significant differences in these genes were observed between WRNexo-null and wild-type midguts before injury (Fig 4A and S1 Table). RT-qPCR validation of selected proteostasis-related genes (Hsp70Ba, Hsp70Bb, Hsp68, Hsp67Ba, and Hsp67Bc) confirmed expression patterns consistent with those observed in RNA-seq results (S4A and S4B Fig). Gene Ontology analysis of differentially expressed genes that were only upregulated or downregulated in the WRNexo-null midguts after BLM-induced injury revealed significant enrichment for genes involved in protein refolding and the cellular response to unfolded proteins (Fig 4B and S2 Table). The UPRER is a cellular stress response triggered by ER stress, which occurs when the protein-folding capacity of the ER is overwhelmed, leading to the accumulation of unfolded or misfolded proteins [52,53]. Upon activation, UPR target genes alleviate ER stress by inducing stress-responsive chaperones [54,55]. The upregulation of multiple proteostasis-related genes in WRNexo-null midguts after injury suggests a potential involvement of WRNexo in the regulation of UPRER. We hypothesize that WRNexo may regulate UPRER activity by suppressing specific proteostasis-related genes.

Fig 4. WRNexo regulates ISC proliferation by regulating the activation of UPRER.

Fig 4

(A) Volcano plots of differentially expressed genes in a pair-wise comparison of WRNexo-null flies and wild-type (WT) flies before and after BLM-REC-1D treatment. (B) Gene Ontology (GO) terms in the biological process (BP) category for differentially expressed genes. Upper panel: Venn diagram of overlap between differentially expressed gene sets from WT flies and WRNexo-null flies before and after BLM-REC-1D treatment. Lower panel: GO term analysis of up- or down-regulated genes limited to the green region in the upper panel. Both the adjusted p-value and gene ratio denote the significance of enrichment. (C–E) Immunofluorescence images of the midguts of flies carrying the esg-gal4>UAS-Xbp1-EGFP reporter system, detecting ER stress through the nuclear translocation of Xbp1-EGFP in UAS-LacZ (C, control), WRNexo RNAi (D), and WRNexo overexpressing flies (E). (F) Quantification of the number of Xbp1-EGFP+ cells per ROI in midguts from (C–E). ROI size was 10,000 μm2, n is as indicated. (G–I) Immunofluorescence images of the midguts of flies carrying the esg-gal4>UAS-Xbp1-EGFP reporter system, detecting ER stress through the nuclear translocation of Xbp1-EGFP in UAS-LacZ (G, control), WRNexo RNAi (H), and WRNexo overexpressing flies (I). Flies were treated with tunicamycin induction for 1 day and then recovery on regular food for 1 day (TM-REC-1D). (J) Quantification of the fluorescence intensity of Xbp1-EGFP+ cell from midguts of experiments in (G–I). Each dot represents a cell, n is as indicated. (K–P) Immunofluorescence images of midguts from flies carrying esgts-GAL4-driven UAS-LacZ (control, K), WRNexo RNAi (L), Xbp1 RNAi (M), WRNexo RNAi with Xbp1 RNAi (N), Hrd1 RNAi (O), and WRNexo RNAi with Hrd1 RNAi (P) under PQ-REC-1D treatment. (Q) Quantification of pH3+ cells per whole midgut from experiments in (K–P). Each red circle represents a midgut, n is as indicated. DAPI-stained nuclei (blue). Scale bars represent 5 μm in C–E, G–I, 25 μm in K–P. Error bars represent SD. Studentt tests, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, and NS (non-significant) represents p > 0.05. See also S4 Fig and S1S3 Tables. Underlying data and statistical analysis in S4 Data.

IRE1/XBP1 is one of the major branches of UPRER signaling pathways in Drosophila [36]. Moreover, previous studies have shown that the IRE1/XBP1 signaling pathway is involved in metabolic adaptation and life span extension under dietary restriction (DR) in Drosophila [56]. Notably, our RNAseq analysis of WRNexo-null midguts revealed significant alterations in genes associated with metabolic processes (S1 and S2 Tables). One such gene, sugarbabe, a key mediator of IRE1/XBP1-regulated lipogenesis [56], displayed significant variation in WRNexo-null midguts (S1 and S2 Tables). Collectively, these findings suggest that WRNexo and UPRER-related genes may collaboratively regulate multiple cellular processes, including metabolic adaptation and ER stress response.

The spliced X-box binding protein 1 (Xbp1s) is a key transcription factor that responds to ER stress and induces genes associated with the UPR, thereby alleviating protein overload in the ER across various Drosophila tissues [5759]. The XBP1-EGFP reporter line is widely used to indicate Xbp1 splicing, with the nuclear translocation of Xbp1s serving as a visual marker of this splicing and ER-stress activation [36,60,61]. Under normal conditions, Xbp1-EGFP signals were barely detectable in esg+ cells of Drosophila, and no activation of Xbp1 splicing was observed (Figs 4C and S4C). When ER stress is activated, it triggers Xbp1 splicing, leading to the nuclear translocation of Xbp1-EGFP (Fig 4G). Our experiments revealed WRNexo overexpression significantly promoted the nuclear translocation of Xbp1-EGFP (Fig 4E and 4F), while WRNexo depletion resulted in undetectable nuclear Xbp1-EGFP levels (Fig 4D and 4F). Tunicamycin (TM), a nucleoside antibiotic that inhibits protein glycosylation, is widely used as an ER-stress inducer [6264]. In our experiments, WRNexo overexpression significantly enhanced nuclear Xbp1 signals in ISCs under TM treatment (Fig 4G, 4I, and 4J), whereas WRNexo depletion suppressed TM-induced Xbp1 nuclear translocation in ISCs (Fig 4G, 4H, and 4J). Collectively, these findings suggest that WRNexo plays a critical role in the ER stress response. To further confirm that WRNexo regulates ISC proliferation by modulating UPRER signaling, we increased ER stress by suppressing key UPR regulator genes, Xbp1 and Hrd1. Specifically, Hrd1 encodes a transmembrane ER protein that facilitates the degradation of misfolded peptides [65,66]. Notably, inhibition of Xbp1 through esg-Gal4-driven RNAi restored ISC proliferation in the injured gut epithelium caused by WRNexo deficiency (Fig 4K4N, and 4Q). Similarly, suppression of Hrd1 also restored ISC proliferation in the injured gut epithelium following WRNexo RNAi (Fig 4K, 4L, and 4O4Q). These findings illustrate that WRNexo regulates ER stress upstream to modulate ISC proliferation through UPRER signaling.

WRNexo promotes ISC proliferation by the inhibition of Hsc70-3

Our experiments indicate that WRNexo regulates ISC proliferation through UPRER signaling (Fig 4K4Q), though the specific mechanism remains unclear. RNA-seq analysis suggests that WRNexo may inhibit proteostasis-related genes, including stress-responsive chaperones (Fig 4A and 4B). We hypothesize that WRNexo modulates UPRER activity by selectively repressing certain UPRER-related genes. To confirm this hypothesis, we conducted nuclear protein extraction followed by immunoprecipitation (IP) and mass spectrometry (MS) (IP-MS) analyses to investigate the involved protein complexes. By analyzing the three independent experiments on midguts isolated from esg-Gal4-driven WRNexo-HA overexpression Drosophila lines, we identified several high-scoring proteins associated with protein folding, ER unfolded protein response, and ROS metabolic process (Fig 5A5C and S4S6 Tables). Surprisingly, among these potential WRNexo-binding proteins, we consistently identified heat shock protein 70 cognate 3 (Hsc70-3/Bip)-an ER-resident chaperone crucial for protein folding and induced by Xbp1s [43,67]-in all independent IP-MS experiments (Fig 5A5C and S4S6 Tables). Furthermore, co-immunoprecipitation (Co-IP) analyses confirmed that WRNexo directly binds to Hsc70-3/Bip (Fig 5D) in Drosophila.

Fig 5. WRNexo promotes ISC proliferation by the inhibition of Hsc70-3.

Fig 5

(A–C) Partial high score proteins (nuclear protein extraction) in mass spectrometry (MS) analysis of midgut isolated from flies carrying esgts-GAL4-driven UAS-WRNexo-3xHA. The Biological Process was analyzed by the DAVID database. Three independent experiments as indicated. (D) Co-immunoprecipitation studies were carried out with lysates prepared from 293T cells (a human embryonic kidney cell line). For the control, 293T cells were co-transfected with Flag-Vector and HA-WRNexo. Simultaneously, 293T cells were co-transfected with Flag-Hsc70-3 and HA-WRNexo. (E) Purified His-Drosophila-WRNexo was incubated with purified GST or GST-Drosophila-Hsc70-3 at 4 °C followed by GST pulldown. Western blotting indicated WRNexo interacted with Hsc70-3. (F–J) Immunofluorescence images of the midguts of flies carrying the esg-gal4>UAS-Xbp1-EGFP reporter system, detecting ER stress through the nuclear translocation of Xbp1-EGFP in UAS-LacZ (F, control), UAS-WRNexo (G), Hsc70-3 RNAi (H), UAS-Hsc70-3 (I), and both overexpression of WRNexo and Hsc70-3 (J). (K) Quantification of the number of Xbp1-EGFP+ cells per ROI in midguts from (F–J). ROI size was 10,000 μm2, n is as indicated. (L–O) Immunofluorescence images of the midgut of flies carrying esgts-GAL4-driven UAS-LacZ (L, control), UAS-WRNexo (M), UAS-Hsc70-3 (N), and combined UAS-WRNexo with UAS-Hsc70-3 (O). (P) Quantification of pH3+ cells from whole midguts of experiment in (L–O). Each red circle represents a midgut, n is as indicated. (Q–T) Immunofluorescence images of the midgut of flies carrying esgts-GAL4-driven UAS-LacZ (Q, control), WRNexo RNAi (R), Hsc70-3 RNAi (S), and combined WRNexo RNAi with Hsc70-3 RNAi (T) with PQ-REC-1D treatment. (U) Quantification of pH3+ cells from whole midguts of experiment in (Q–T). Each red circle represents a midgut, n is as indicated. DAPI-stained nuclei (blue). Scale bars represent 5 μm in F–J, 25 μm in L–O, and Q–T. Error bars represent SD. Student t tests, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, and NS (non-significant) represents p > 0.05. See also S4 Fig and S3S6 Tables. Underlying data and statistical analysis in S5 Data.

We acknowledged that Co-IP alone may not conclusively establish a direct interaction between the two proteins. Therefore, we undertook additional experiments, including using AlphaFold to predict their interaction and performing a pull-down assay to confirm it. AlphaFold predictions strongly suggest that Drosophila WRNexo (127aa-357aa) directly interacts with Drosophila Hsc70-3/Bip protein (S4D Fig). Furthermore, the pull-down assays confirmed the direct interaction between Drosophila WRNexo (127aa-357aa) (the WRNexo ortholog in human) [38] and Drosophila Hsc70-3/Bip protein (Fig 5E). These data indicate that WRNexo interacts directly with Hsc70-3/Bip in ISCs.

Hsc70-3/Bip (as a key ER stress-responsive regulator) is a direct downstream target of the Xbp1 transcription factor in the regulation of ISC proliferation during Drosophila aging [36,57]. Similar to WRNexo overexpression, it has been reported that depleting Hsc70-3 in esg+ cells activates ISC proliferation in Drosophila midguts [36]. A previous study confirmed that excessive activation of UPRER signaling can be induced either by misexpressing mutant proteins or by knocking down the ER chaperone Hsc70-3/Bip [6870]. Therefore, we hypothesized that the overexpressed WRNexo may inhibit Hsc70-3 function by interacting with it.

To investigate whether WRNexo affects UPRER signaling and ISC proliferation through its interaction with Hsc70-3, we conducted genetic experiments. Hsc70-3/Bip knockdown mimicked the effects of WRNexo overexpression, enhancing UPRER signaling as indicated by the nuclear localization of XBP1-EGFP (Fig 5F5H, and 5K). In contrast, co-expression of Hsc70-3/Bip and WRNexo attenuated the nuclear localization of XBP1-EGFP, suggesting that WRNexo modulates UPRER signaling through its interaction with Hsc70-3/Bip (Fig 5F5G and 5I5K). To further confirm the role of WRNexo and Hsc70-3 in ISC proliferation, we examined their genetic interaction. As expected, overexpression of Hsc70-3 rescued the esg-GFP+ and pH3+ cell accumulation in WRNexo-overexpressing midguts (Fig 5L5P). Additionally, deletion of Hsc70-3 restored ISC proliferation in WRNexo-null midguts following injury (Fig 5Q5U). These data suggest that WRNexo maintains ISC-mediated gut homeostasis by modulating the UPRER signaling through the inhibition of Hsc70-3.

Age-associated WRNexo elevation promotes gut hyperplasia via oxidative stress and JNK signaling

Since WRNexo expression increases in ISCs with aging (Figs 1N1B′ and S1CS1J), and the overexpression of WRNexo in young ISCs results in a phenotype resembling gut hyperplasia in old Drosophila (Fig 2Y and 2A′), we predicted that the age-associated increase in WRNexo expression may contribute to age-related gut hyperplasia. To test this hypothesis, we used esg-Gal4-driven WRNexo RNAi to inhibit WRNexo expression in middle-age (30-day-old) Drosophila. Depleting WRNexo reduced age-associated ISC over-proliferation and gut hyperplasia, as indicated by the decreases in esg+ cells and pH3+ cells in the midguts of aged Drosophila (Fig 6A6D). Furthermore, WRNexo overexpression in young ISCs significantly shortens Drosophila life span (Fig 6E). In contrast, reducing WRNexo expression in middle-aged flies (30 days old, maintained at 18°C until induction) markedly extended their life span compared to controls (Fig 6F).

Fig 6. Age-related upregulation of WRNexo induces gut hyperplasia through ROS signaling.

Fig 6

(A, B) Immunofluorescence images of the midguts of flies carrying esgts-GAL4-driven UAS-LacZ (control, A) and WRNexo RNAi (B). Flies were raised on regular food and at a repressive temperature (18 °C) for 30 days after eclosion, then shifted to a permissive temperature (29 °C) for 7 days with normal conditions before dissection. (C) Quantification of pH3+ cells from whole midguts of experiments in (A, B). Each dot represents a midgut, n is as indicated. (D) Quantification of esg-GFP+ cells in the ROI from midguts of experiments in (A, B). ROI size 10,000 μm2, n is as indicated. (E) Survival rate of flies carrying esgts-GAL4-driven UAS-WRNexo raised on a permissive temperature (29 °C). Flies carrying esgts-GAL4-driven UAS-LacZ served as controls. (F) Survival rate of flies carrying esgts-GAL4-driven UAS-LacZ (control) and UAS-WRNexo. raised on a permissive temperature (29 °C). Flies were raised on regular food and at a repressive temperature (18 °C) for 30 days after eclosion, then shifted to a permissive temperature (29 °C). (G, H) Immunofluorescence of p-eIF2α staining in human colons. Normal young para-carcinoma colons (as Young, the mean age was 29 years, n = 4, G), normal old para-carcinoma colons from patients with colon cancer (as Old, the mean age was 67 years, n = 7, H). Cells were stained by p-eIF2α (red). The boxed areas in (G, H) are enlarged to the right. (I) Quantification of the fluorescence intensity of p-eIF2α in experiments (G, H). Each dot represents one cell of boxed regions from crypts. Colon samples were from four young patients and seven old patients. (J) Western blotting results indicate an increase in p-eIF2α expression in the colons upon aging. Loading controls, GAPDH. Colon samples were from four young patients and seven old patients. (K) Quantification of the relative band intensity of p-eIF2α as shown in experiments (J). (L–N) Dihydro-ethidium (DHE) staining of live intestines from flies carrying esgts-GAL4-driven UAS-LacZ (L, control), WRNexo RNAi (M) or UAS-WRNexo (N). DHE single channel is separated in the lower panel. Dashed circles indicate esg+ cells. (O) Quantification of the fluorescence intensity of DHE per esg-GFP+ cell from experiments (L–N). n is as indicated. (P, Q) DHE staining of live intestines carrying esgts-GAL4-driven UAS- LacZ (P, control) or WRNexo RNAi (Q) with PQ-REC-1D treatment. DHE single channel is separated in the lower panel. The dashed circle indicates esg-GFP+ cells. (R) Quantification of the fluorescence intensity of DHE per esg-GFP+ cell from experiments (P, Q). n is as indicated. (S–V) Repression of Keap1 (Keap1 RNAi) (T), overexpression of CncC (U), or overexpression of Cat (V), all of which could limit ISC proliferation under WRNexo overexpression background (S). (W, X) Quantification of pH3+ cells from whole midguts (W) and esg-GFP+ cells in a 10,000 μm2 area from midguts (X) of experiments in (S–V). n is as indicated. (Y) Schematic summary of the mechanism underlying ISC proliferation caused by WRNexo upregulation in ISCs during aging or regeneration. DAPI-stained nuclei (blue). Scale bars represent 5 μm in L–N and P–Q, 25 μm in A, B, and S–V, 50 μm in G and H. Error bars represent SD. Student t tests, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, and NS (non-significant) represents p > 0.05. See also S5 and S6 Figs and S3 Table. Underlying data and statistical analysis in S6 Data.

To further investigate whether the increase of WRN expression in the crypts of aged colons regulates ISC behavior by the modulation of the UPRER, we analyzed colon tissues from elderly individuals. We observed significantly higher levels of phosphorylated eukaryotic initiation factor 2 alpha (p-eIF2α, which is widely used to marker the activation of UPRER) [37] in normal colons from elderly individuals compared to those of young controls (Fig 6G6I). Western blotting further confirmed that p-eIF2α levels were elevated in elderly colons (Fig 6J and 6K). Furthermore, immunostaining analyses revealed an increase in the expression of p-eIF2α in Drosophila midguts during aging (S5A, S5C, and S5E Fig). Notably, overexpression of WRNexo in young flies led to an upregulation of p-eIF2α (S5A, S5B, and S5E Fig), while p-eIF2α levels were significantly reduced in aged flies with WRNexo knockdown (S5CS5E Fig). These findings suggest that WRN may play a role in human gut homeostasis and aging through a UPRER-mediated mechanism in ISCs.

Prior research has demonstrated that the UPRER involves the proliferation of ISC in Drosophila through oxidative stress signaling [36]. Besides, WRNexo may involve the process of response to oxidative stress (Fig 5A5C, and S4S6 Tables). Consequently, we conducted additional investigations to determine whether WRNexo also stimulates ROS activation in ISCs. To ascertain if WRNexo elevates ROS levels in midguts, we employed dihydroethidium (DHE) for monitoring of endogenous ROS levels in vivo [71]. Knocking down WRNexo in esg+ cells under normal conditions did not significantly change the level of ROS in esg+ cells when compared to levels in the control (Fig 6L, 6M, and 6O). ROS levels were higher in esg+ cells with WRNexo overexpressed than in the control (Fig 6L, 6N, and 6O). Given that PQ can elevate intracellular ROS levels [21], we measured ROS levels in flies expressing WRNexo RNAi under the control of esgts-Gal4 after PQ-induced injury. ROS levels in esg+ cells were significantly lower in WRNexo RNAi flies than in controls after PQ treatment (Fig 6P6R). Furthermore, we used the MitoTimer (MitoTimer encodes a mitochondria-tagged green fluorescent protein and shows a shift to red when the proteins are oxidized) reporter line to detect the cellular redox state [72]. We found that the overexpression of WRNexo in esg+ cells could elevate ROS levels compared to those in controls (S5FS5H Fig).

Given that previous studies have demonstrated that the regulation of the cellular redox state by CncC, Keap1, and Catalase (Cat) (Fig 5A5C and S4S6 Tables) [31,34], we investigated the genetic interaction between WRNexo and these genes associated with ROS. Our results showed that reduction of cellular ROS levels, achieved by either overexpressing Cat or CncC or by depleting Keap1, could reverse the ISC proliferation induced by WRNexo overexpression in esg+ cells (Fig 6S6X). The findings indicated that the increase in ISC proliferation induced by WRNexo overexpression could be reversed by reducing cellular ROS.

Previous studies have reported that UPRER-related gut dysplasia in Drosophila is caused by the activation of JNK signaling in ISCs upon aging [36,57]. Accordingly, we evaluated whether WRNexo causes ISC hyperplasia via JNK signaling. As expected, the expression of pJNK was increased with WRNexo overexpressing during homeostasis and decreased in aged flies with WRNexo depletion (S6AS6D Fig). Moreover, the expression of a dominant-negative (DN) version of Basket (Bsk; the Drosophila homolog of JNK) reduced ISC proliferation in Drosophila with Hsc70-3 RNAi following gut injury (S6ES6H Fig). The expression of constitutively active (CA) Hemipterous (Hep; which encodes a JNK kinase in Drosophila) restored ISC proliferation defects in WRNexo RNAi flies after injury (S6I–S6M Fig). Furthermore, we found that gut hyperplasia caused by WRNexo overexpression was rescued by expressing a DN version of Bsk (S6N–S6Q Fig). These results suggested that JNK activation is necessary for WRNexo to promote ISC proliferation. Altogether, WRNexo upregulation in ISCs of aged Drosophila causes ISC hyper-proliferation and gut dysplasia by promoting UPRER-mediated ROS and JNK signaling (Fig 6Y).

Age-associated WRNexo elevation is induced by the accumulation of DNA double-strand breaks in ISCs

In young Drosophila midguts, ISCs are predominantly quiescent but are rapidly activated to proliferate and replenish damaged epithelial cells following gut injury [35]. As Drosophila age, the proportion of quiescent ISCs gradually decreases, leading to gut hyperplasia characterized by the accumulation of esg+ and Dl+ cells in the midguts [10,21]. Our study revealed that injury signals from the gut epithelium induce WRNexo upregulation in ISCs of young Drosophila midguts. However, the underlying mechanism driving the age-related increase in WRNexo expression in ISCs remains unclear, warranting further investigation into the regulatory pathways contributing to this phenomenon.

The accumulation of DNA double-strand breaks (DSBs) is a well-defined hallmark of animal aging [5,35]. Interestingly, WRN is a key regulator for the repair of DSBs in cultured human cells [6], and studies have shown that DSB induction leads to WRN accumulation in these cells [73]. In Drosophila, WRNexo depletion has been reported to disrupts the genome integrity in wing hairs [38,46] and increase DSBs levels in embryos [39]. Therefore, we hypothesized that the age-related upregulation of WRNexo in ISCs might be linked to the accumulation of DSBs during aging.

To test this hypothesis, we analyzed double-staining confocal images of γH2AvD, a marker for DSBs in Drosophila, and endogenous WRNexo-mCherry in ISCs of aging flies. Our results revealed that WRNexo upregulation in ISCs and EBs closely correlated with the distribution pattern of DSBs in aged flies (Fig 7A7D). In addition, a much higher γH2AvD signal was detected in the ISCs and EBs of young flies with WRNexo-depleted in esg+ cells (Fig 7E7G).

Fig 7. Age-associated WRNexo elevation is induced by the accumulation of DNA double-strand breaks in ISCs.

Fig 7

(A, B) Immunofluorescence images of young (A) and old (B) midguts of flies carrying esg-GFP and WRNexo-mCherry endogenous reporter. γH2AvD single channel image is shown in the lower panel. The boxed areas in immunofluorescence images of GFP, mCherry, and γH2AvD staining are enlarged on the right. (C) Quantification of the fluorescence intensity of γH2AvD in per WRNexo-mCherry+ cell of young (A) and old (B) midguts. Each dot represents a WRNexo-mCherry+ cell, n is as indicated. (D) Quantification of the fluorescence intensity of WRNexo-mCherry per esg-GFP+ cell of young (A) and old (B) midguts. Each dot represents an esg-GFP+ cells, n is as indicated. (E, F) Representative images of the young midgut of flies carrying esgts-GAL4-driven UAS-LacZ (control, E) and WRNexo RNAi (F) under permissive temperature, stained with γH2AvD and GFP. Dashed line indicates esg-GFP+ cells. The boxed areas in immunofluorescence images of γH2AvD and GFP staining are enlarged on the right. (G) Quantification of the fluorescence intensity of γH2AvD per esg-GFP+ cell of midguts from control (E) and depletion of WRNexo in esg+ cells (F). Each dot represents an esg-GFP+ cell, n is as indicated. (H) Quantification of the fluorescence intensity of γH2AvD per esg-GFP+ cell of midguts from control (I) and WRNexo-overexpressing esg+ cells (J). Each dot represents an esg-GFP+ cell, n is as indicated. (I, J) Representative images of aged (35 days) midguts of flies carrying esgts-GAL4-driven UAS-LacZ (control, I) and WRNexo overexpression vectors (J), stained with γH2AvD and GFP. The boxed areas in immunofluorescence images of GFP, Delta, and γH2AvD staining are enlarged on the right. (K) Immunofluorescence images of the control (non-γ-irradiation treatment, upper panel) and γ-irradiation (lower panel) midguts from flies carrying esg-GFP and WRNexo-mCherry endogenous reporters. The boxed areas in immunofluorescence images of GFP and mCherry staining are enlarged on the right. (L) Immunofluorescence images of the control (non-γ-irradiation treatment, upper panel) and γ-irradiation (lower panel) midguts from flies carrying esg-GFP endogenous reporters. The boxed areas in immunofluorescence images of GFP and γH2AvD staining are enlarged on the right. (M) Quantification of the fluorescence intensity of WRNexo-mCherry midgut-derived per esg-GFP+ cell of control (upper panel, K) and γ-irradiation treatment (lower panel, K). Each dot represents an esg-GFP+ cell, n is as indicated. (N) Quantification of the fluorescence intensity of γH2AvD midgut-derived per esg-GFP+ cell of control (upper panel, L) and γ-irradiation treatment (lower panel, L). Each dot represents an esg-GFP+ cell, n is as indicated. (O) In Drosophila ISCs, WRNexo upregulation and Hsc70-3/Bip translocation to nuclei occur with injury/aging. WRNexo interaction inhibits Hsc70-3/Bip, increasing ER stress, which promotes ISC proliferation via ROS-JNK signaling. DAPI-stained nuclei (blue). Scale bars represent 5 μm in A, B, K, and L, 10 μm in E, F, I, and J. Error bars represent SDs. Student t tests, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, and NS (non-significant) represents p > 0.05. See also S7 Fig and S3 Table. Underlying data and statistical analysis in S7 Data.

The overexpression of WRNexo by esg-Gal4 significantly reduced the γH2AvD signal in Dl+ ISCs of aged Drosophila compared to control flies (Fig 7H7J). To directly induce DSBs, we employed γ-irradiation [74,75] and observed that DSBs indeed promoted the upregulation of WRNexo in Drosophila ISCs (Fig 7K7N). To further investigate the association between DNA damage and WRNexo expression, we manipulated DNA damage repair genes, such as ATM and Chk1 [76]. Specifically, knockdown of ATM or Chk1, which impairs DNA repair capacity, in middle-aged flies led to a significant increase in WRNexo expression in ISCs (S7A7H Fig). This result was consistent with our observations from γ-Irradiation experiments (Fig 7K7N). Collectively, these findings suggest that the increase in WRNexo expression in ISCs of aging flies is likely associated with the accumulation of DNA damage in ISCs.

Discussion

WRN deficiency is a known cause of adult progeria (Werner syndrome), and as such, it has been extensively studied in cultured cells derived from Werner syndrome patients and in model organisms with WRN depletion [6,73,77]. However, its physiological role in normal tissue homeostasis and natural aging remains poorly understood. WRN protein primarily functions as a DNA helicase in cells, which has been implicated in the accumulation of DNA damage—a key factor proposed to drive cellular senescence [78,79]. Consistent with this, cells from Werner syndrome patients display heightened genomic instability and hypersensitivity to DNA damage-inducing agents [80,81]. Interestingly, some studies have reported that inhibitors of WRN helicase activity do not induce hypersensitivity in WRN-deficient cells, and their drug sensitivity profiles instead implicate the exonuclease function of WRN [81,82]. Moreover, homozygous point mutations that inactivate WRN helicase activity have been shown not to result in clinical manifestations of Werner syndrome [83], further highlighting the importance of the exonuclease function. Drosophila WRN (WRNexo), which lacks helicase activity and retains only exonuclease function, offers a unique model system to specifically investigate the role of WRN exonuclease activity in aging and tissue homeostasis. This model system may help clarify the distinct contributions of WRN enzymatic functions in aging-related pathologies. While as WRN’s helicase activity may contribute to its role in aging in humans, future investigations should focus on mammalian models to determine whether WRN upregulation represents a conserved mechanism underlying stem cell aging and age-related pathologies in humans.

Our study demonstrates that WRNexo in ISCs is essential for gut epithelial repair under the normal homeostatic state but contributes to gut hyperplasia during aging. WRNexo expression is highly induced in ISCs upon gut epithelial damage or in response to DNA damage accumulation in aged animals. The elevated WRNexo interacts with Hsc70-3/Bip, a key ER stress-responsive regulator, and inhibits its activity. This inhibition leads to ER stress, upregulates ROS-JNK signaling, and ultimately drives ISC hyper-proliferation (Fig 7O). This study provides the first evidence that WRNexo plays a dual role: it is critical for stem cell-mediated tissue regeneration but also promotes age-associated tissue dysplasia.

It is essential to emphasize that our study presents evidence that the absence of WRNexo does not trigger the UPR during homeostasis. However, following gut injury, proteostasis-related genes such as Hsp67Ba, Hsp67Bc, Hsp68, and Hsp70 family become activated in WRNexo-deficient conditions. Recent studies have shown that human ER luminal chaperone GRP78 (also known as Bip and encoded by the HSPA5 gene), an ortholog of Drosophila Hsc70-3 [84], is up-regulated and translocated to the nucleus in cancer and stressed cells [85]. Based on this evidence, we hypothesized that the up-regulation and nuclear translocation of GRP78 might explain why Hsc70-3 translocates to the nucleus and interacts with the WRNexo protein (Figs 5A5C, and 7O and S4S6 Tables). Earlier investigations have unveiled the coordinated interplay between UPRER and ROS in regulating the proliferation of ISCs [36]. In line with these findings, we observed that the absence of WRNexo prevented the elevation of cellular ROS levels upon PQ exposure. This observation aligns with recent research demonstrating that impaired mitochondrial function and metabolic dysfunction are hallmark features of Werner syndrome [86,87]. Additionally, previous studies have highlighted the role of the IRE1/XBP1 signaling pathway module in metabolic adaptation under DR in flies [56]. Transcriptomic analysis of Drosophila midgut ECs under DR revealed significant changes in genes related to metabolic processes, such as GstD9, Lip3, and CG10383 [56]. Intriguingly, our RNAseq analysis of WRNexo-null midguts identified similar alterations in metabolic processes, with notable changes in the expression of these genes (Fig 4B and S1 and S2 Tables). These findings suggest a conserved link between WRNexo, metabolic regulation, and gut homeostasis.

Over the past decade, studies of WRN have focused on its role in Werner syndrome, while little is known about its function in natural aging. A prior study demonstrated that WRN levels were significantly lower in primary dental pulp mesenchymal stem cells derived from old individuals compared to young individuals [6]. However, in vivo studies examining WRN expression in ISCs during normal aging are largely absent. The endogenous WRNexo reporter line, WRNexo-mCherry, revealed that WRNexo expression was primarily confined to esg+ ISCs and EBs, with minimal expression in fully differentiated ECs and EEs in Drosophila midguts. These results suggest that WRNexo functions in stem and/or progenitor cells. We further demonstrated that the age-associated increase in WRNexo expression in ISCs is a response to accumulation of DNA damage. WRNexo upregulation was shown to be essential for maintaining gut homeostasis and facilitating acute regenerative responses. However, chronic overexpression of WRNexo in ISCs during aging leads to detrimental effects, contributing to gut dysplasia in older flies. These findings provide novel insights into how WRN expression dynamics contribute to age-associated tissue dysfunction.

The progressive decline of proliferative homeostasis is a hallmark of aging in the intestinal epithelium, contributing to age-associated diseases such as colorectal cancers. The long-term maintenance of intestinal epithelial homeostasis depends on ISCs. However, due to their longevity and frequent replication, ISCs are more susceptible than terminally differentiated epithelial cells to endogenous and exogenous stressors, including DNA damage, oxidative stress, and ER stress [88]. To counteract these challenges, stem cells have evolved effective repair or response mechanisms, such as DNA damage response (DDR), UPRER, and diverse antioxidants [35,89]. Although substantial progress has been made in elucidating the signaling pathways and responses to these stressors, the specific factors driving stem cell aging remain poorly understood. Using Drosophila ISCs as a model, our findings suggest that the accumulation of DNA damage is a key contributor to increased WRNexo levels during aging (Fig 7). Aging, however, is a multifaceted process influenced by factors such as elevated ROS production and ER stress, both of which may also play roles in regulating WRNexo expression. Further studies are needed to explore the complex interplay between these factors and their contributions to WRNexo regulation during aging.

An effective DDR is essential for the longevity and high replication potential of stem cells. While DDR impairment has been implicated in tumor formation [90], the potential side effects of its over-activation remain largely unexplored. Recent studies have demonstrated that WRN activation is critical for the survival of cancer cells characterized by MSI [7,8]. Consequently, WRN is now being investigated as a novel DDR target in preclinical and clinical studies [91]. Our findings in the Drosophila midgut model suggest that WRNexo over-activation may promote tumorigenesis by inducing ER-stress and upregulating JNK signaling. This study highlights a potential mechanism by which over-active DDR could exacerbate tumor development through enhanced ER stress and its downstream signaling pathways.

ER stress and the UPRER are well-studied in the context of stem cell aging [35,61]. Impairment of the UPRER results in the accumulation of misfolded proteins in the ER of aged stem cells [35,36]. While numerous studies have focused on the downstream effects and signaling factors of the UPRER [36,37,60], the upstream regulation of the UPRER remains largely unexplored. In our study, we found that WRNexo regulates UPRER activation by interacting with Hsc70-3/Bip. Our results identify a previously unrecognized mechanism underlying alterations in the UPRER in Drosophila ISCs during aging. Future studies should focus on elucidating the detailed mechanism through which WRNexo interacts with Hsc70-3/Bip to regulate the transcription of other UPR-related genes in ISCs. This will provide further insight into how UPRER dysregulation contributes to stem cell aging and associated pathologies.

Materials and methods

Human samples

Human colon tissues from patients with colorectal carcinoma were provided by Doctor Lishou Xiong of the First Affiliated Hospital of Sun Yat-sen University. The intestinal tissues were collected from 13 patients with peritumoral tissues and 4 patients with colorectal cancer at the First Affiliated Hospital of Sun Yat-sen University (see Table 1 for detailed patient information). The gut samples were checked on the day of surgery and mucosal biopsies were ensured during endoscopy. Patients had pathologically and clinically diagnosed colorectal cancer [92,93].

Table 1. Demographic and clinical characteristics of all participants.

Participant characteristics PT CRC
Number of patients 13 4
Age, years (median, range) 61 (26–71) 33 (26–37)
Gender (male/female) 8/5 3/1

PT, peritumoral tissue; CRC, colorectal cancer.

Colon segments were resected during surgery, and normal and tumor/disease tissues were separated. All participants provided written informed consent for this study. This study protocol complied with the ethical guidelines of the 1975 Declaration of Helsinki principles and was approved by the Human Ethics Committee of Sun Yat-sen University (Approval numbers: [2022] No. 133).

Drosophila breeding and maintenance

The age and rearing conditions of Drosophila are described in the text, figures, legends, and Methods. The stocks of Drosophila were maintained on standard yeast food (cornmeal 50 g, yeast 18.5 g, sucrose 80 g, glucose 20 g, agar 5 g, and propionic acid 30 mL combined in 1 L of water) at 25 °C, 65% humidity, and on a normal 12-h light/dark daylight cycle, unless otherwise stated.

The temporal and regional gene expression targeting method was used for Gal4-UAS-mediated RNAi and overexpression experiments. To repress the Gal4 system, the crosses were maintained at 18°C when driving temperature-sensitive Gal4-mediated RNAi or gene overexpression. During eclosion or at a certain age after eclosion, adults were shifted to 29 °C to turn on the Gal4 system, which induces RNAi or gene overexpression. Enclosed flies were incubated at 29 °C for the indicated time period, followed by the dissection of midguts for immunostaining or western blotting. Mated females were used for experiments on the Drosophila midguts. All fly lines were backcrossed into the w1118 background for six generations, and sibling populations were derived from the crosses. The unmarked fly lines were genotyped by non-lethal PCR genotyping using adult wings from individual Drosophila, as previously described [94,95]. Only flies with the correct genotype were selected for the next round of backcrossing. The final offspring, which had successfully passed the backcrossing process, were used for experimentation.

For the aging-associated experiments, tub-Gal80ts transgenic Drosophila combined with esg-Gal4 were grown at a permissive temperature (18 °C) to limit Gal4 activity. Adult flies were raised at 18 °C for 30 days after eclosion, then transferred to a non-permissive temperature (29 °C) for 7 days until the dissection of midguts for immunostaining analyses.

Drosophila lines

All Drosophila strains used in this study are female and listed below. All genotypes for experimental crosses are provided in S3 Table.

The following Drosophila lines and stocks were collected from the Bloomington Drosophila Stock Center (BDSC), the Vienna Drosophila Resource Center (VDRC), the TsingHua Fly Center (THFC), or the Zurich ORFeome Project (FlyORF).

The following Drosophila lines were obtained from the FlyORF: UAS-CncC (F000602) and UAS-Hsc70-3(F000956). The following Drosophila lines were obtained from the BDSC: The w1118 allele (BDSC3605) was used as the wild-type control. UAS-LacZ (BDSC 8529), UAS-LacZ (BDSC 3956), UAS-GFP (BDSC 4776), how-Gal4 (BDSC 1767), UAS-WRNexo RNAi (BDSC 38297), UAS-Xbp1-EGFP (BDSC 60730), Xbp1 RNAi (BDSC 36755), Hrd1 RNAi (BDSC 50609), keap1 RNAi (BDSC 40932), UAS-Cat (BDSC 24621), UAS-hepCA (BDSC 6406), Hsc70-3 RNAi (BDSC 32402), UAS-BSKDN (BDSC 6409), and UAS-Mito Timer (BDSC 57323). The following Drosophila lines were obtained from the VDRC: UAS-WRNexo RNAi (VDRC 100227), UAS-WRNexo RNAi (VDRC 44595) and btl-Gal4 (VDRC 109128). The following Drosophila lines were obtained from the THFC: ATM RNAi (THU5591) and Chk1 RNAi (THU2601).

The following Drosophila lines were kindly provided as indicated: esg-GFP line, esg-Gal4 line, and tub-Gal4 line by Dr. Allan Spradling; esgts-Gal4 line, MyolAts-Gal4 line, ISCts-Gal4 line, Rab3ts-Gal4 line, NREts-Gal4 line, and reporter line NRE-lacZ by Dr. Benjamin Ohlstein; FRT82B and esgts, UAS-flp, act>CD2>gal4, UAS-GFP line provided by Dr. Zheng Guo. The following Drosophila lines were available in our laboratory: WRNexo-mcherry, WRNexo Mutant WRNexo10, WRNexo12, WRNexo15, UAS-WRNexo-3×HA, and UAS-WRNexo.

Mouse samples

A total of 80 male C57BL/6J mice (six weeks of age) with a weight range of 18–22 g were obtained from GemPharmatech Co., Ltd (Nanjing, Jiangsu, China). The mice were housed under an automated 12-h light/dark cycle, with a controlled relative humidity of 40%–50% and a temperature of 22 ± 2 °C, and were provided with a standard dry diet and tap water ad libitum. The animals received humane care, and all experimental procedures were performed in accordance with the guidelines for the health and care of experimental animals established by Sichuan University (Chengdu, China). Ethical approval was granted (Permit Number: 202203170).

Method details

Generation of WRNexo mutant and transgenic lines

Three WRNexo null mutants were generated by Cas9-mediated gene knockout, as described previously [96]. The following guide RNAs were used:

single-guide RNA-1-Forward:

  • 5′-GTCGGAAAAGCAAATGAAGTTCCCA-3′

  • single-guide RNA-1-Reverse:

  • 5′-AAACTGGGAACTTCATTTGCTTTTC-3′

  • single-guide RNA-2-Forward:

  • 5′-GTCGAGGAGACTCCCAAAGTGGCA-3′

  • single-guide RNA-2-Reverse:

  • 5′-AAACTGCCACTTTGGGAGTCTCCT-3′

The transgenic Drosophila lines UAS-WRNexo and UAS-WRNexo-3×HA were constructed in-house. In brief, cDNA of WRNexo was cloned into the pEntry or pEntry-3×HA vector [97] using the pEASY-Uni Seamless Cloning and Assembly Kit (CU101-02; TransGen Biotech, Beijing, China). Then, the previous product was sub-cloned into the pTW vector by LR recombination. Finally, the vectors were cloned, verified by sequencing, and sent to UniHuaii Corporation (Zhuhai, China) for Drosophila embryo injection. The WRNexo cDNA primers were as follows:

  • WRNexo L: 5′-TTGCGGCCGCATGGAAAAATATTTAACAAAAATGCCCA-3′;

  • WRNexo R: 5′-ATGGGTAGAGACCCAGAGTCACCTCGTTGATCTTGGT-3′.

Knock-in lines were made in-house. WRNexo-mCherry lines and various vectors were verified by sequencing and injected through Fungene Biotechnology (Beijing, China). To construct knock-in Drosophila lines, two constructs were generated, one with two sgRNAs and another with the homologous recombination sequence. The two sgRNAs were used to generate specific gene deletion regions. The sgRNA sequence was composed in vitro and sub-cloned into a PMD18T vector to get the U6 promoter. The U6 promoter and sgRNAs were amplified by PCR in the PMD18T vector. Two products with the U6 promoter and sgRNAs were sub-cloned into the PCR8 vector by Golden Gate assembly and recombined into the attB vector by LR recombination to generate the sgRNA construct. To generate the homologous recombinant, the 5′ homology arm (~1 kb), mCherry, and the 3′ homology arm (~1 kb) were inserted into the PASK vector (obtained from the Fungene Biotechnology). The 5′ homology arm and 3′ homology arm were used to repair homologous recombination and mCherry was introduced by homologous recombination. The sgRNAs were designed using http://targetfinder.flycrispr.neuro.brown.edu/ and are listed below.

Target1-WRNexo-sgRNA:

  • Forward: 5′-GTCGAGATCAACGAGGTGACTCTG-3′

  • Reverse: 5′-AAACCAGAGTCACCTCGTTGATCT-3′

Target2-WRNexo-sgRNA:

  • Forward: 5′-GTCGTCTAATTCCTTTTACCTGTT-3′

  • Reverse: 5′-AAACAACAGGTAAAAGGAATTAGA-3′

Primers for mCherry and loxP in the vector:

  • Forward: 5′-GTGAGCAAGGGC-GAGGAGGAT-3′

  • Reverse: 5′-ATAACTTCGTATAATGTATGCTATACGAAGTTATCAGCT-TCGCATGGTT-3′

  • Primers for the vector arm:

5′ Arm:

  • Forward: 5′-CCTCTTCGCTATTACGCCAGGATGGAGGAAG-AAAATCCGCCCA-3′;

  • Reverse: 5′-ATCCTCCTCGCCCTTGCTCACACCTCCCAGAGTCACCTCGTTGA-TCTTCGTCAGAAA-3′.

3′ Arm:

  • Forward: 5′-GCATACATTATACGAAGTTATGCTTTTCTTTGAAG-TTTCAGATATGCGATCTAATT-3′.

  • Reverse: 5′-GCTATGACCATGATTACGCCACATGAGGCATCCACAACAGCGCA-3′.

Mosaic analysis with a repressible cell marker

We used WRNexo mutant and FLP/FRT-mediated mitotic recombination technique to generate WRNexo-null MARCM clones. The WRNexo10, WRNexo12, and WRNexo15 respectively, carrying the FRT82B line was obtained as a gift from Dr. Zheng Guo. To generate UAS-WRNexo MARCM clones, FRT82B was crossed to UAS-WRNexo to produce UAS-WRNexo/cyo; FRT82B/TM6B flies. Then, these Drosophila were crossed to yw hsFLP::tub-Gal4::UAS-nls GFP/FM7;+/+; tubG80 FRT82B/TM6B (a gift from Dr. Zheng Guo) was used to obtain yw hsFLP::tub-Gal4::UAS-nls GFP/+; WRNexo10 or 12::tubG80 FRT82B/ FRT82B, and yw hsFLP::tub-Gal4::UAS-nls GFP/+; UAS-WRNexo/+; WRNexo10 or 12::tubG80 FRT82B/ FRT82B flies. The crosses were kept at 25 °C.

For MARCM clone production, adult Drosophila were fed at 25 °C for 2–3 days and heat-shocked at 37 °C for 1 h twice. After heat-shock treatment, Drosophila were kept at 25 °C. These flies were dissected and observed at 10 days after clone induction.

Genotyping unmarked fly lines

Non-lethal PCR genotyping was performed using adult wings, following previously described methods [94,95]. In summary, a pair of adult wings from individual Drosophila was collected and placed in PCR tubes. Next, 20 μL of PCR mix containing Platinum SuperFi DNA Polymerase (Invitrogen; Catalog #12351010) and amplification primers was added. The PCR products were subsequently analyzed using electrophoresis on a 1% agarose gel containing ethidium bromide.

Paraquat, bleomycin, and tunicamycin treatment

Adult female Drosophila were transferred from medium to empty bottles for 2 h. The filter paper was cut into 3.5 × 6.0 cm pieces and treated with 5% (wt/vol) sucrose with 10 mM PQ, 50 μg/mL tunicamycin (TM), or 25 µg/mL BLM. Then, the moist papers were added to empty bottles for 24 h, and Drosophila were transferred into a new standard medium without PQ or TM. Identical Drosophila fed 5% sucrose were used as controls. PQ-, BLM-, or TM-induced damage experiments were performed in a temperature-controlled incubator at 25 °C, unless otherwise specified.

For RNAi or overexpression experiments with PQ, BLM, or TM treatment, the GAL4ts lines and UAS lines were maintained at 18 °C to repress the Gal4 system. One day after eclosion, the adults were shifted to 29 °C to activate the Gal4 system, which induces RNAi or overexpression. Enclosed flies were incubated at 29 °C for 5 days. Then, Drosophila were starved in empty vials for 2 h and treated in 5% (wt/vol) sucrose with 10 mM PQ, 25 µg/mL BLM, or 50 μg/mL TM for 24 h, followed by recovery for 24 h. The controls were treated in the same way in parallel. The process of PQ, BLM, or TM treatment was performed at 29 °C.

Immunostaining and microscopy analyses of Drosophila tissues

Guts were dissected in phosphate-buffered saline (PBS) and immersed in PBS with 4% EM-paraformaldehyde (PBS formula: 100 mM glutamic acid, 25 mM KCl, 20 mM MgSO4, 4.5 mM Na2HPO4, 1 mM MgCl2, pH 7.4) at room temperature (25 °C) for 45 min. Guts were washed in PBST (PBS, 0.1% Triton X-100) three times, 15 min each, followed by incubation with primary and second antibodies in PBST after soaking in BSA (PBS, 0.5% BSA, 0.1% Triton X-100) for 30 min. The primary antibodies are shown in Table 2.

Table 2. List of antibodies.

Antibodies Source Use and Dilution
Rabbit anti-WRN Abcam Cat# ab200 IF 1:800
Mouse anti-WRN(F-33) Santa Cruz Cat# sc-101110 WB 1:400
Chicken polyclonal anti-GFP Abcam Cat# ab13970 IF 1:1000
Rat monoclonal anti-mCherry Invitrogen Cat# M11217 IF 1:500
Chicken anti-β-Galactosidase Abcam Cat# ab9361 IF 1:1000
Rabbit anti-HA (C29F4) Cell Signaling Technology Cat# 3724 IF 1:1000
Mouse anti-Armadillo DSHB Cat# N2 7A1 IF: 1:50
Mouse anti-Delta DSHB Cat# C594.9B IF 1:100
Mouse anti-Prospero DSHB Cat# MR1A IF 1:200
Rabbit anti-phosphoHistone H3 (Ser10) Millipore Cat# 06-570 IF 1:1000
Rabbit anti-p-eIf2α Cell Signaling Technology Cat# 3597 IF 1:200; WB 1:1000
Rabbit anti-γ‐H2AvD Rockland Cat# 600‐401‐914 IF 1:1000
Mouse anti-β-tubulin RayBiotech
Cat# RM2003
WB 1:1000
Mouse anti-GAPDH Beyotime Biotechnology Cat# AF0006 WB 1:500
Rabbit anti-pJNK (pTPpY) Promega Cat# V7931 IF 1:1000

Confocal images were acquired by a Leica TCS-SP8 confocal microscope. Images for each set of experiments were acquired as confocal stacks under the same settings, including 1,024 × 1,024 resolution and bi-direction scanning. The gain value up reached 800 and offset was arranged from −0.1% to −0.2% in each image. To illuminate the Z-axis detail and optimize clarity, images were acquired as confocal z-stacks with numbers usually ranging from 5 to 10 and finally projected to one image. Adobe Photoshop CS5 and Adobe Illustrator 2021 were used to assemble the images. The midgut cells were counted using a Leica DM6-B microscope.

Immunofluorescence for human colonic tissue analyses

Gut sections were incubated in xylene twice (15 min each) and dehydrated in 100% ethanol twice (5 min each). They were then dehydrated in 85% and 75% gradient ethanol (5 min each). After cleaning in distilled water, the sections were immersed in EDTA antigen retrieval buffer (pH 8.0) and maintained at a sub-boiling temperature for 8 min, left standing for 8 min, and maintained at a sub-boiling temperature for an additional 8 min. Sections were kept at room temperature to cool down and washed with PBS (pH 7.4) three times in a shaker (5 min each). After washing in flowing distilled water, sample sections were blocked in 0.5% BSA blocking solution for 30 min. Samples were then incubated with primary buffer at 4 °C overnight.

After washing with PBS three times (5 min each) in the shaker, the sections were incubated with the secondary buffer at 4 °C overnight, followed by incubation with DAPI solution at room temperature for 10 min in the dark.

After staining with DAPI, sections were mounted in mounting medium. Fluorescence images were obtained using the Leica TCS-SP8 confocal microscope.

Gut lysate and western blotting analyses

Human colon tissues or isolated mouse crypts were mixed in RIPA Lysis Buffer (P0013B; Beyotime Biotechnology, Haimen, China) with appropriate protease inhibitors and then transferred to liquid nitrogen. The tissues were placed on ice 30 min after using a grinding rod for homogenization. The lysate supernatant was collected and total proteins were quantified using the PierceRapid Gold BCA Protein Assay Kit (A53226; Thermo). Each sample was supplemented with 5× loading buffer and boiled for 12 min. The protein gels were transferred to polyvinylidene difluoride (PVDF) membranes and blocked with 5% TBST with defatted milk for 1 h. After blocking, samples were incubated in the primary antibody overnight at 4 °C and washed with TBST three times at 25 °C (10 min each). PVDF membranes were incubated with the horseradish peroxidase-labeled secondary antibody in the dark and shaking about 2 h at room temperature.

Antibodies for western blotting are shown in Table 2. The secondary antibodies were horseradish peroxidase-conjugated Goat anti-mouse (Beyotime Biotechnology, #A0216, 1:1,000) and Goat anti-rabbit (Thermo, #A0208, 1:1,000).

RT-qPCR

One hundred midguts were dissected from female flies per group in the experiment. Flies were dissected in 4 °C diethylpyrocarbonate (DEPC)-treated water-PBS, incubated in 1 mg/mL Elastase (Sigma, Cat. No. E0258) combined DEPC-PBS at room temperature, and mixed gently five times every 15 min. After dissociation, the samples were centrifuged at 400g for 20 min at 4 °C, re-suspended in 4 °C DEPC-treated water-PBS, filtered with 70 mm filters (Biologix, Sao Paolo, Brazil). As the meanwhile, whole midguts from female flies were used to achieve total RNA using the TRIzol reagent (Thermo Fisher Scientific, Waltham, MA, USA) following the user guide. The PrimeScript RT Reagent Kit (TaKaRa, Kusatsu, Japan) was used to synthesize cDNA. RNA was reverse-transcribed by oligo dT. First-strand cDNA was diluted with sterile water 50 times and used for real-time PCR using the Quant-Studio 5 System (Thermo Fisher Scientific) and SYBRGreen (Genestar, Irvine, CA, USA). The reference standard group was Rp49, and expression levels were counted by the 2–∆∆CT method. The expression level of the standard sample was normalized to 1.0. All primer sequences for qPCR are available upon reasonable request. Primer sequences used for qPCR are available upon request.

RNA-Seq and data analysis

The Drosophila crosses were cultured on normal food at 25°C. w1118 Drosophila were used as the control for WRNexo-null mutant Drosophila (WRN10/WRN12). WRNexo-null and wild-type flies were maintained at room temperature for homeostasis or injury assays. About 50 female flies for each biological replicate were dissected in PBS on ice. Midguts were frozen on drikold and isothiocyanate-alcoholphenyl-chloroform was used to collect total RNA after dissection. Then, total RNA was sent to Berry Genomics Corporation (Beijing, China) for sequencing on the NovaSeq 6000 platform (Illumina, San Diego, CA, USA). Quality control was performed using FastQC (version 0.11.8).

The raw RNA-seq data with read lengths of 150 bp were aligned to the Drosophila reference genome (Ensembl BDGP6 release-89). The aligned reads (sam files) were transferred to bam files and sorted using SAMtools. Gene expression levels in different samples were determined using DESeq2 (version 1.22.2). Differential expression was verified if p ≤ 0.05 following Benjamini–Hochberg correction.

Fluorescence intensity analyses

Immunofluorescence images were analyzed by confocal microscopy. The fluorescence intensity statistics in the region of interest (ROI) were calculated using ImageJ. The detailed process for the quantitative analysis of fluorescence intensity was described previously [97]. Briefly, the steps were as follows.

Open image: File -> Open.

Split Channels: Image -> Color -> Split Channels. Select the channel for calculation and strike out redundant channels.

Scale Setting: Analyze -> Set scale -> Click to remove scale. Set the scale in pixels.

Measurements Setting: Analyze -> Set Measurements. Choose the boxes “Area,” “Integrated Density,” and “limit to threshold.” Click the “OK” box.

Choose the ROI or cell by different kinds of drawing/selection tools and select another smaller region around the ROI or cell as background.

Choose different types of ROI, cells, and background regions using “ROI Manager.”

Select “Measure” and calculate the integrated density.

Integrated density = Integrated density of ROI or cell − Integrated density of background region/Area of background region × Area of ROI or cell.

Gray value analysis of western blotting bands

A gray value analysis of bands obtained by western blotting was performed using ImageJ. The specific methods were as follows.

File -> Open. Choose the selected image.

Edit -> Invert.

Analyze -> Set Scale -> Choose the image scale to remove. Set the scale in pixel.

Analyze -> Set Measurements. Choose the bottom of “Area” -> “Mean Gray Value,” limited to threshold, and choose the bottom of “OK.”

Pick up the band region and choose a smaller area as the background.

Choose the ROI Manager to select the band and background regions.

Click the “Measure” box to compute the average gray value.

(Band gray value = (Mean gray value of band region × Area of band region) − (Background Mean gray value × Area of background region)).

Lifespan assays

For survival tests under normal conditions, 100 female flies in three groups (2 days old) with the same phenotype (w1118, WRNexo10/15, and WRNexo10/12) were collected and fed in a temperature-controlled incubator at 25 °C. For life span assays involving WRNexo overexpression, 50 female flies per group (2 days old, initially reared at 18 °C) were transferred to a temperature-controlled incubator at 29 °C to activate the UAS-Gal4 system. For life span assays involving WRNexo knockdown, 100 female flies per group (30 days old, initially maintained at 18 °C) were transferred to 29 °C. In all assays, the flies were monitored daily for survival, with the living flies transferred to fresh food tubes every 2 days.

Cell fractionation and mass spectrometry

The midguts of Drosophila were rinsed and collected using chilled PBS. Subsequently, the nuclear and cytoplasmic components were isolated utilizing a Nuclear-Cytoplasmic Protein Extraction Kit (Beyotime, Shanghai, China, Catalog #P0028), following the protocols suggested by the manufacturer.

Proteins were separated by SDS-PAGE, and the gel bands were excised from the gel. For in-gel tryptic digestion, gel pieces were destained in 50 mM NH4HCO3 in 50% acetonitrile (v/v) until clear. Gel pieces were dehydrated with 100 μl of 100% acetonitrile for 5 min, the liquid removed, and the gel pieces rehydrated in 10 mM dithiothreitol and incubated at 56 °C for 60 min. Gel pieces were again dehydrated in 100% acetonitrile, liquid was removed and gel pieces were rehydrated with 55 mM iodoacetamide. Samples were incubated at room temperature, in the dark for 45 min. Gel pieces were washed with 50 mM NH4HCO3 and dehydrated with 100% acetonitrile. Gel pieces were rehydrated with 10 ng/μl trypsin resuspended in 50 mM NH4HCO3 on ice for 1 h. Excess liquid was removed and gel pieces were digested with trypsin at 37 °C overnight. Peptides were extracted with 50% acetonitrile/5% formic acid, followed by 100% acetonitrile. Peptides were dried to completion and resuspended in 2% acetonitrile/0.1% formic acid.

Peptides were dissolved in 0.1% FA (formic acid, Sigma), 2% CAN (Acetonitrile, Thermo), directly loaded onto a reversed-phase analytical column (75 umi.d.× 150 mm, packed with Acclaim PepMap RSLC C18, 2 um, 100Å, nanoViper). The gradient was comprised of an increase from 5% to 50% solvent B (0.1% FA, 80% ACN) over 40 min, and climbing to 90% in 5 min, then holding at 90% for the 5 min. The flow rate was 300 nl/min. The MS analysis was performed on QExactiveTM Mass Spectrometer (Thermo). The peptides were subjected to NSI source followed by tandem mass spectrometry (MS/MS) in Q ExactiveTM Mass Spectrometer coupled online to the HPLC. Intact peptides were detected in the Orbitrap at a resolution of 70,000 and peptides were selected for MS/MS using NCE setting as 27. The ion fragments were detected in the Orbitrap at a resolution of 17, 500. A data-dependent procedure that alternated between one MS scan followed by 20 MS/MS scans was applied for the top 20 precursor ions above a threshold ion count of 1E4 in the MS survey scan with 30.0 s dynamic exclusion. The electrospray voltage applied was 2.0 kV. Automatic gain control was used to prevent overfilling of the ion trap and 1E5 ions were accumulated for the generation of MS/MS spectra. For MS scans, the m/z scan range was 350–1,800 m/z. The fixed first mass was set as 100 m/z.

Protein identification was performed with MASCOT software by searching Uniprot Drosophila melanogaster. Searching Parameters are as follows:

  • Fixed modifications: Carbamidomethyl (C)

  • Variable modifications: Oxidation (M)

  • Enzyme: Trypsin

  • Maximum Missed Cleavages: 2

  • Peptide Mass Tolerance: 10 ppm

  • Fragment Mass Tolerance: 0.6 Da

  • Mass values: Monoisotopic

  • Significance threshold: 0.05

Co-immunoprecipitation assay

For the Co-IP assay, pCDNA3.1-Flag or pCDNA3.1-Flag-Hsc70-3 and pCDNA3.1-HA-WRNexo were co-transfected into HEK293T cells seeded in a 10 cm cell culture dish. After 48 h of transfection, transfected cells were harvested, lysed using lysis buffer following the anti-FLAG M2 gel protocol (Cat# A2220; Millipore, Billerica, MA, USA). After the supernatant was collected, protein concentrations were determined using BCA kit. For IP, anti-FLAG M2 gel was added to the supernatant and rotated head-over-tail at 4 °C for 2 h. The beads were washed for 10 min (six times) with lysis buffer. Immunoprecipitated proteins and input samples were analyzed by western blotting after elution with 3× FLAG peptide.

Pull-down assay

The transgenic plasmid of pet21a- Drosophila-WRNexo (aa127-aa357) and pGEX-6P-1-Drosophila-Hsc70-3 were constructed in-house. In brief, cDNA of WRNexo and Hsc70-3 were cloned into the pet21a and pGEX-6P-1 using the pEASY-Uni Seamless Cloning and Assembly Kit (CU101-02; TransGen Biotech, Beijing, China). The cDNA primers were as follows:

  • PET21a-Drosophila-WRNexo-F: ATGGGTCGCGGATCCGAATTCggtgctataaagtatt

  • PET21a-Drosophila-WRNexo-R: GTGGTGGTGGTGGTGCTCGAGgagaggaaatttact

  • GST-Drosophila-Hsc70-3/Bip-F: TTCCAGGGGCCCCTGGGATCCatgaagttatgcatatta

  • GST-Drosophila-Hsc70-3/Bip-R: CTCGAGTCGACCCGGGAATTCcagctcgtccttgagatc

His-tagged WRNexo and GST-tagged Hsc70-3/Bip were expressed in BL21 (DE3) bacterias and purified by using Ni-NTA agarose (Qiagen) or Glutathione agarose (Sigma), respectively. GST pull-down experiment was performed in the buffer containing 20 mM of Tris-HCl (pH 8.0), 90 mM of NaCl, 0.5 mM of EDTA, 1 mM of DTT, 10% glycerol, and 0.1% Tween. GST-tagged beads were washed for three times. (Washing buffer: 20 mM of Tris-HCl (pH 8.0), 120 mM of NaCl,0.1% Tween.) Equal amounts of GST or GST-tagged Hsc70-3/Bip proteins were incubated with GST-tagged beads for 1 h at 4 °C. Then, his-tagged WRNexo (three times of GST-tagged proteins) were incubated with the element above for 1 h at 4 °C.

ROS measurement with DHE

The ROS content was analyzed as described previously [34]. Drosophila midguts were dissected in Schneider’s medium (HyClone) and transferred to 30 μM DHE (Invitrogen, Waltham, MA, USA) in a dark box for 5 min of incubation. Then, guts were washed by Schneider’s medium three times and used to make slides to capture images as soon as possible. The confocal microscopy sections (568 nm excitation, 550–610 nm detection, fixed laser power, gain and offset settings) were used to obtain images. Signal intensities for the intestinal epithelium were measured using ImageJ, and ISCs were identified by esg-GFP expression.

γ-Irradiation treatment

Drosophila were maintained at 25 °C and 60% humidity with a normal dark/light cycle. Adult flies (7 days) were collected in small collection discs, each containing 20 adult flies. As previous reports described [75], adult flies were irradiated in the γ-irradiation machine with a dose rate of 2.55 Gy/min for 5 Gy dose. After the irradiated flies were incubated for 1 h at 25 °C, the midguts were dissected for immunostaining.

Statistical analyses

GraphPad Prism v7.0 was used for statistical analyses after verifying the normality and equivalence of variances. Data are presented as the means ± standard deviation from at least three independent biological replicates, unless otherwise specified. Statistical significance was determined using two-tailed Student’s t-tests, unless otherwise specified. Significance is stated in the text or figure legends. For all tests, p < 0.05 was considered statistically significant.

Software

R (version 3.5.3; downloaded from https://www.r-project.org/) was used for downstream analyses of RNA-seq data. Custom ImageJ was used for immunofluorescent staining and western blotting quantification (downloaded from https://imagej.nih.gov/ij/). Prism 7.0 (GraphPad) was also used (downloaded from https://www.graphpad.com/).

Supporting information

S1 Fig. WRNexo is expressed in Drosophila midguts and the expression increases with aging, related to Fig 1.

Underlying data and statistical analysis in S1 Data.

(DOCX)

pbio.3003121.s001.docx (1.4MB, docx)
S2 Fig. WRNexo is essential for gut homeostasis, related to Fig 2.

Underlying data and statistical analysis in S2 Data.

(DOCX)

pbio.3003121.s002.docx (916.7KB, docx)
S3 Fig. WRNexo functions cell-autonomously in ISCs to promote ISC proliferation, related to Fig 3.

(DOCX)

pbio.3003121.s003.docx (1.2MB, docx)
S4 Fig. WRNexo protein directly interacts with protein Hsc70-3/Bip, related to Figs 4 and 5.

Underlying data and statistical analysis in S4 Data.

(DOCX)

pbio.3003121.s004.docx (501.6KB, docx)
S5 Fig. WRNexo regulates the cellular redox state and modulates ISC proliferation by UPRER pathway, related to Fig 6.

Underlying data and statistical analysis in S6 Data.

(DOCX)

pbio.3003121.s005.docx (937.3KB, docx)
S6 Fig. WRNexo regulates ISC proliferation by Hsc70−3 and JNK signaling, related to Fig 6.

Underlying data and statistical analysis in S6 Data.

(DOCX)

pbio.3003121.s006.docx (1.3MB, docx)
S7 Fig. DNA double strands break induces WRNexo expression, related to Fig 7.

Underlying data and statistical analysis in S7 Data.

(DOCX)

pbio.3003121.s007.docx (1.3MB, docx)
S1 Table. List of gene counts from RNA-seq without BLM injury (WT and WRNexo-null), normalized by the DESeq2 R package, related to Fig 4.

Gene symbols are indicated.

(XLSX)

pbio.3003121.s008.xlsx (1,003.2KB, xlsx)
S2 Table. List of gene counts from RNA-seq with BLM injury (WT and WRNexo-null), normalized by the DESeq2 R package, related to Fig 4.

Gene symbols are indicated.

(XLSX)

S3 Table. Full Drosophila genotypes as they appear in each figure panel, related to Figs 17 and S1S7.

(XLSX)

pbio.3003121.s010.xlsx (13.9KB, xlsx)
S4 Table. Initial mass spectrometry (MASS) analysis was performed on nuclear proteins extracted from the midguts of flies carrying an esgts-GAL4-driven UAS-WRNexo-3xHA.

(XLSX)

pbio.3003121.s011.xlsx (25.2KB, xlsx)
S5 Table. The second mass spectrometry (MASS) analysis of nuclear proteins extracted from the midguts of flies with esgts-GAL4-driven UAS-WRNexo-3xHA was performed.

(XLSX)

pbio.3003121.s012.xlsx (32.9KB, xlsx)
S6 Table. The third mass spectrometry (MASS) analysis was performed on nuclear proteins extracted from the midguts of flies carrying an esgts-GAL4-driven UAS-WRNexo-3xHA.

(XLSX)

pbio.3003121.s013.xlsx (16.4KB, xlsx)
S1 Data. Underlying data for Figs 1 and S1.

(XLSX)

pbio.3003121.s014.xlsx (34.1KB, xlsx)
S2 Data. Underlying data for Figs 2 and S2.

(XLSX)

pbio.3003121.s015.xlsx (35.4KB, xlsx)
S3 Data. Underlying data for Fig 3.

(XLSX)

pbio.3003121.s016.xlsx (20.4KB, xlsx)
S4 Data. Underlying data for Figs 4 and S4.

(XLSX)

pbio.3003121.s017.xlsx (18.4KB, xlsx)
S5 Data. Underlying data for Fig 5.

(XLSX)

pbio.3003121.s018.xlsx (11.9KB, xlsx)
S6 Data. Underlying data for Figs 6, S5, and S6.

(XLSX)

pbio.3003121.s019.xlsx (32.3KB, xlsx)
S7 Data. Underlying data for Figs 7 and S7.

(XLSX)

pbio.3003121.s020.xlsx (23KB, xlsx)
S1 Raw Images. Raw Images for Figs 1D, 1K, 5D, 5E, and 6J.

(PDF)

pbio.3003121.s021.pdf (1.8MB, pdf)

Acknowledgments

We thank BDSC, VDRC, and TsingHua Fly Center for fly strains, and DSHB for antibodies.

Abbreviations:

ACI

after clone induction

BDSC

Bloomington Drosophila Stock Center

BLM

bleomycin

Bsk

Basket

CA

constitutively active

Cat

Catalase

DDR

DNA damage response

DEPC

diethylpyrocarbonate

DHE

dihydroethidium

Dl+

Delta+

DN

dominant-negative

DR

dietary restriction

DSBs

DNA double-strand breaks

EBs

enteroblasts

ECs

enterocytes

EEs

enteroendocrine cells

ER

endoplasmic reticulum

Hep

Hemipterous

Hsc70-3/Bip

Heat shock 70-kDa protein cognate 3

IP

immunoprecipitation

ISCs

intestinal stem cells

JNK

c-Jun N-terminal kinase

MARCM

mosaic analysis with a repressible cell marker

MS

mass spectrometry

MSI

microsatellite instability

PBS

phosphate-buffered saline

PQ

paraquat

Pros+

Prospero+

PVDF

polyvinylidene difluoride

RNA-seq

RNA-sequencing

ROI

region of interest

ROS

reactive oxygen species

RT-qPCR

real-time quantitative PCR

THFC

TsingHua Fly Center

TM

tunicamycin

UPRER

unfolded protein response of the endoplasmic reticulum

VDRC

Vienna Drosophila Resource Center

WRN

Werner syndrome

WRNexo

Werner syndrome exonuclease

Xbp1s

spliced X-box binding protein 1

Data Availability

All data presented are available in the main text or the supplementary materials. The RNA-seq data supporting this study have been deposited in PRJNA944585 (Fig 4A, 4B), with source data provided in S1 and S2 Tables.

Funding Statement

This work was supported by the National Key R&D Program of China (2020YFA0803602), the National Natural Science Foundation of China (32470879 and 92157109) (H.C.), Sichuan Science and Technology Program, Sichuan Provincial Natural Science Foundation (Grant NO. 2025ZNSFSC0720 (H.C.)), and the 1·3·5 project for disciplines of excellence, West China Hospital, Sichuan University (ZYYC20024) (HC), and 1·3·5 projects for Artificial Intelligence (ZYAI24024), West China Hospital, Sichuan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Kudlow BA, Kennedy BK, Monnat RJ Jr. Werner and Hutchinson-Gilford progeria syndromes: mechanistic basis of human progeroid diseases. Nat Rev Mol Cell Biol. 2007;8(5):394–404. doi: 10.1038/nrm2161 [DOI] [PubMed] [Google Scholar]
  • 2.Huang S, Lee L, Hanson NB, Lenaerts C, Hoehn H, Poot M, et al. The spectrum of WRN mutations in Werner syndrome patients. Hum Mutat. 2006;27(6):558–67. doi: 10.1002/humu.20337 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Uhrhammer NA, Lafarge L, Dos Santos L, Domaszewska A, Lange M, Yang Y, et al. Werner syndrome and mutations of the WRN and LMNA genes in France. Hum Mutat. 2006;27(7):718–9. doi: 10.1002/humu.9435 [DOI] [PubMed] [Google Scholar]
  • 4.Oshima J, Sidorova JM, Monnat RJ Jr. Werner syndrome: clinical features, pathogenesis and potential therapeutic interventions. Ageing Res Rev. 2017;33:105–14. doi: 10.1016/j.arr.2016.03.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194–217. doi: 10.1016/j.cell.2013.05.039 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zhang W, Li J, Suzuki K, Qu J, Wang P, Zhou J, et al. Aging stem cells. A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging. Science. 2015;348(6239):1160–3. doi: 10.1126/science.aaa1356 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Chan EM, Shibue T, McFarland JM, Gaeta B, Ghandi M, Dumont N, et al. WRN helicase is a synthetic lethal target in microsatellite unstable cancers. Nature. 2019;568(7753):551–6. doi: 10.1038/s41586-019-1102-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Behan FM, Iorio F, Picco G, Gonçalves E, Beaver CM, Migliardi G, et al. Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens. Nature. 2019;568(7753):511–6. doi: 10.1038/s41586-019-1103-9 [DOI] [PubMed] [Google Scholar]
  • 9.Leiszter K, Galamb O, Sipos F, Tóth K, Valcz G, Patai VA, et al. Age-related microscopic and molecular changes of the human colon, and their role in the development of colorectal cancer in elderly people. Orv Hetil. 2010;151(22):885–92. doi: 10.1556/OH.2010.28882 [DOI] [PubMed] [Google Scholar]
  • 10.Jasper H. Intestinal stem cell aging: origins and interventions. Annu Rev Physiol. 2020;82:203–26. doi: 10.1146/annurev-physiol-021119-034359 [DOI] [PubMed] [Google Scholar]
  • 11.Ohlstein B, Spradling A. The adult Drosophila posterior midgut is maintained by pluripotent stem cells. Nature. 2006;439(7075):470–4. doi: 10.1038/nature04333 [DOI] [PubMed] [Google Scholar]
  • 12.Micchelli CA, Perrimon N. Evidence that stem cells reside in the adult Drosophila midgut epithelium. Nature. 2006;439(7075):475–9. doi: 10.1038/nature04371 [DOI] [PubMed] [Google Scholar]
  • 13.Jiang H, Edgar BA. Intestinal stem cell function in Drosophila and mice. Curr Opin Genet Dev. 2012;22(4):354–60. doi: 10.1016/j.gde.2012.04.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Biteau B, Hochmuth CE, Jasper H. Maintaining tissue homeostasis: dynamic control of somatic stem cell activity. Cell Stem Cell. 2011;9(5):402–11. doi: 10.1016/j.stem.2011.10.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Guo Z, Lucchetta E, Rafel N, Ohlstein B. Maintenance of the adult Drosophila intestine: all roads lead to homeostasis. Curr Opin Genet Dev. 2016;40:81–6. doi: 10.1016/j.gde.2016.06.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Chen J, Xu N, Wang C, Huang P, Huang H, Jin Z, et al. Transient Scute activation via a self-stimulatory loop directs enteroendocrine cell pair specification from self-renewing intestinal stem cells. Nat Cell Biol. 2018;20(2):152–61. doi: 10.1038/s41556-017-0020-0 [DOI] [PubMed] [Google Scholar]
  • 17.Guo Z, Ohlstein B. Stem cell regulation. Bidirectional Notch signaling regulates Drosophila intestinal stem cell multipotency. Science. 2015;350(6263):aab0988. doi: 10.1126/science.aab0988 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.He L, Si G, Huang J, Samuel ADT, Perrimon N. Mechanical regulation of stem-cell differentiation by the stretch-activated Piezo channel. Nature. 2018;555(7694):103–6. doi: 10.1038/nature25744 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Wang C, Guo X, Xi R. EGFR and Notch signaling respectively regulate proliferative activity and multiple cell lineage differentiation of Drosophila gastric stem cells. Cell Res. 2014;24(5):610–27. doi: 10.1038/cr.2014.27 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Jiang H, Edgar BA. EGFR signaling regulates the proliferation of Drosophila adult midgut progenitors. Development. 2009;136(3):483–93. doi: 10.1242/dev.026955 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Biteau B, Hochmuth CE, Jasper H. JNK activity in somatic stem cells causes loss of tissue homeostasis in the aging Drosophila gut. Cell Stem Cell. 2008;3(4):442–55. doi: 10.1016/j.stem.2008.07.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Zhai Z, Kondo S, Ha N, Boquete J-P, Brunner M, Ueda R, et al. Accumulation of differentiating intestinal stem cell progenies drives tumorigenesis. Nat Commun. 2015;6:10219. doi: 10.1038/ncomms10219 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Chen J, Xu N, Huang H, Cai T, Xi R. A feedback amplification loop between stem cells and their progeny promotes tissue regeneration and tumorigenesis. Elife. 2016;5:e14330. doi: 10.7554/eLife.14330 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Cheng C-W, Adams GB, Perin L, Wei M, Zhou X, Lam BS, et al. Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell Stem Cell. 2014;14(6):810–23. doi: 10.1016/j.stem.2014.04.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Biteau B, Karpac J, Supoyo S, Degennaro M, Lehmann R, Jasper H. Lifespan extension by preserving proliferative homeostasis in Drosophila. PLoS Genet. 2010;6(10):e1001159. doi: 10.1371/journal.pgen.1001159 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kao S-H, Tseng C-Y, Wan C-L, Su Y-H, Hsieh C-C, Pi H, et al. Aging and insulin signaling differentially control normal and tumorous germline stem cells. Aging Cell. 2015;14(1):25–34. doi: 10.1111/acel.12288 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Ramos A, Camargo FD. The Hippo signaling pathway and stem cell biology. Trends Cell Biol. 2012;22(7):339–46. doi: 10.1016/j.tcb.2012.04.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Bejsovec A. Wingless/Wnt signaling in Drosophila: the pattern and the pathway. Mol Reprod Dev. 2013;80(11):882–94. doi: 10.1002/mrd.22228 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Lin G, Xu N, Xi R. Paracrine Wingless signalling controls self-renewal of Drosophila intestinal stem cells. Nature. 2008;455(7216):1119–23. doi: 10.1038/nature07329 [DOI] [PubMed] [Google Scholar]
  • 30.Tian A, Jiang J. Intestinal epithelium-derived BMP controls stem cell self-renewal in Drosophila adult midgut. Elife. 2014;3:e01857. doi: 10.7554/eLife.01857 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Choi N-H, Kim J-G, Yang D-J, Kim Y-S, Yoo M-A. Age-related changes in Drosophila midgut are associated with PVF2, a PDGF/VEGF-like growth factor. Aging Cell. 2008;7(3):318–34. doi: 10.1111/j.1474-9726.2008.00380.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Chen H, Zheng X, Zheng Y. Age-associated loss of lamin-B leads to systemic inflammation and gut hyperplasia. Cell. 2014;159(4):829–43. doi: 10.1016/j.cell.2014.10.028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Zhao X, Golic FT, Harrison BR, Manoj M, Hoffman EV, Simon N, et al. The metabolome as a biomarker of aging in Drosophila melanogaster. Aging Cell. 2022;21(2):e13548. doi: 10.1111/acel.13548 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Hochmuth CE, Biteau B, Bohmann D, Jasper H. Redox regulation by Keap1 and Nrf2 controls intestinal stem cell proliferation in Drosophila. Cell Stem Cell. 2011;8(2):188–99. doi: 10.1016/j.stem.2010.12.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Rodriguez-Fernandez IA, Tauc HM, Jasper H. Hallmarks of aging Drosophila intestinal stem cells. Mech Ageing Dev. 2020;190:111285. doi: 10.1016/j.mad.2020.111285 [DOI] [PubMed] [Google Scholar]
  • 36.Wang L, Zeng X, Ryoo HD, Jasper H. Integration of UPRER and oxidative stress signaling in the control of intestinal stem cell proliferation. PLoS Genet. 2014;10(8):e1004568. doi: 10.1371/journal.pgen.1004568 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Wang L, Ryoo HD, Qi Y, Jasper H. PERK Limits Drosophila lifespan by promoting intestinal stem cell proliferation in response to ER tress. PLoS Genet. 2015;11(5):e1005220. doi: 10.1371/journal.pgen.1005220 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Saunders RDC, Boubriak I, Clancy DJ, Cox LS. Identification and characterization of a Drosophila ortholog of WRN exonuclease that is required to maintain genome integrity. Aging Cell. 2008;7(3):418–25. doi: 10.1111/j.1474-9726.2008.00388.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Bolterstein E, Rivero R, Marquez M, McVey M. The Drosophila Werner exonuclease participates in an exonuclease-independent response to replication stress. Genetics. 2014;197(2):643–52. doi: 10.1534/genetics.114.164228 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Cassidy D, Epiney DG, Salameh C, Zhou LT, Salomon RN, Schirmer AE, et al. Evidence for premature aging in a Drosophila model of Werner syndrome. Exp Gerontol. 2019;127:110733. doi: 10.1016/j.exger.2019.110733 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Boubriak I, Mason PA, Clancy DJ, Dockray J, Saunders RDC, Cox LS. DmWRNexo is a 3’-5’ exonuclease: phenotypic and biochemical characterization of mutants of the Drosophila orthologue of human WRN exonuclease. Biogerontology. 2009;10(3):267–77. doi: 10.1007/s10522-008-9181-3 [DOI] [PubMed] [Google Scholar]
  • 42.Mason PA, Boubriak I, Robbins T, Lasala R, Saunders R, Cox LS. The Drosophila orthologue of progeroid human WRN exonuclease, DmWRNexo, cleaves replication substrates but is inhibited by uracil or abasic sites : analysis of DmWRNexo activity in vitro. Age (Dordr). 2013;35(3):793–806. doi: 10.1007/s11357-012-9411-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Yang S, Jiang H, Bian W, Xu W, Guo Y, Song S, et al. Bip-Yorkie interaction determines oncogenic and tumor-suppressive roles of Ire1/Xbp1s activation. Proc Natl Acad Sci U S A. 2022;119(42):e2202133119. doi: 10.1073/pnas.2202133119 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Hetz C, Zhang K, Kaufman RJ. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol. 2020;21(8):421–38. doi: 10.1038/s41580-020-0250-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Stainier DYR. No organ left behind: tales of gut development and evolution. Science. 2005;307(5717):1902–4. doi: 10.1126/science.1108709 [DOI] [PubMed] [Google Scholar]
  • 46.Cox LS, Clancy DJ, Boubriak I, Saunders RDC. Modeling Werner Syndrome in Drosophila melanogaster: hyper-recombination in flies lacking WRN-like exonuclease. Ann N Y Acad Sci. 2007;1119:274–88. doi: 10.1196/annals.1404.009 [DOI] [PubMed] [Google Scholar]
  • 47.Guo L, Karpac J, Tran SL, Jasper H. PGRP-SC2 promotes gut immune homeostasis to limit commensal dysbiosis and extend lifespan. Cell. 2014;156(1–2):109–22. doi: 10.1016/j.cell.2013.12.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Miguel-Aliaga I, Jasper H, Lemaitre B. Anatomy and physiology of the digestive tract of Drosophila melanogaster. Genetics. 2018;210(2):357–96. doi: 10.1534/genetics.118.300224 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Amcheslavsky A, Jiang J, Ip YT. Tissue damage-induced intestinal stem cell division in Drosophila. Cell Stem Cell. 2009;4(1):49–61. doi: 10.1016/j.stem.2008.10.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Ren F, Shi Q, Chen Y, Jiang A, Ip YT, Jiang H, et al. Drosophila Myc integrates multiple signaling pathways to regulate intestinal stem cell proliferation during midgut regeneration. Cell Res. 2013;23(9):1133–46. doi: 10.1038/cr.2013.101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Zeng X, Chauhan C, Hou SX. Characterization of midgut stem cell- and enteroblast-specific Gal4 lines in Drosophila. Genesis. 2010;48(10):607–11. doi: 10.1002/dvg.20661 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol. 2012;13(2):89–102. doi: 10.1038/nrm3270 [DOI] [PubMed] [Google Scholar]
  • 53.Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science. 2011;334(6059):1081–6. doi: 10.1126/science.1209038 [DOI] [PubMed] [Google Scholar]
  • 54.Salminen A, Kaarniranta K. ER stress and hormetic regulation of the aging process. Ageing Res Rev. 2010;9(3):211–7. doi: 10.1016/j.arr.2010.04.003 [DOI] [PubMed] [Google Scholar]
  • 55.Tower J. Hsps and aging. Trends Endocrinol Metab. 2009;20(5):216–22. doi: 10.1016/j.tem.2008.12.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Luis NM, Wang L, Ortega M, Deng H, Katewa SD, Li PW-L, et al. Intestinal IRE1 is required for increased triglyceride metabolism and longer lifespan under dietary restriction. Cell Rep. 2016;17(5):1207–16. doi: 10.1016/j.celrep.2016.10.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Katsube H, Hinami Y, Yamazoe T, Inoue YH. Endoplasmic reticulum stress-induced cellular dysfunction and cell death in insulin-producing cells results in diabetes-like phenotypes in Drosophila. Biol Open. 2019;8(12):bio046524. doi: 10.1242/bio.046524 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Coelho DS, Cairrão F, Zeng X, Pires E, Coelho AV, Ron D, et al. Xbp1-independent Ire1 signaling is required for photoreceptor differentiation and rhabdomere morphogenesis in Drosophila. Cell Rep. 2013;5(3):791–801. doi: 10.1016/j.celrep.2013.09.046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Edenharter O, Schneuwly S, Navarro JA. Mitofusin-dependent ER stress triggers glial dysfunction and nervous system degeneration in a Drosophila model of Friedreich’s ataxia. Front Mol Neurosci. 2018;11:38. doi: 10.3389/fnmol.2018.00038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Sone M, Zeng X, Larese J, Ryoo HD. A modified UPR stress sensing system reveals a novel tissue distribution of IRE1/XBP1 activity during normal Drosophila development. Cell Stress Chaperones. 2013;18(3):307–19. doi: 10.1007/s12192-012-0383-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Du G, Liu Z, Yu Z, Zhuo Z, Zhu Y, Zhou J, et al. Taurine represses age-associated gut hyperplasia in Drosophila via counteracting endoplasmic reticulum stress. Aging Cell. 2021;20(3):e13319. doi: 10.1111/acel.13319 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Dorner AJ, Bole DG, Kaufman RJ. The relationship of N-linked glycosylation and heavy chain-binding protein association with the secretion of glycoproteins. J Cell Biol. 1987;105(6 Pt 1):2665–74. doi: 10.1083/jcb.105.6.2665 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Chow CY, Wolfner MF, Clark AG. Using natural variation in Drosophila to discover previously unknown endoplasmic reticulum stress genes. Proc Natl Acad Sci U S A. 2013;110(22):9013–8. doi: 10.1073/pnas.1307125110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Lin C-C, Ding C-KC, Sun T, Wu J, Chen K-Y, Zhou P, et al. The regulation of ferroptosis by MESH1 through the activation of the integrative stress response. Cell Death Dis. 2021;12(8):727. doi: 10.1038/s41419-021-04018-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Baldridge RD, Rapoport TA. Autoubiquitination of the Hrd1 ligase triggers protein retrotranslocation in ERAD. Cell. 2016;166(2):394–407. doi: 10.1016/j.cell.2016.05.048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Bordallo J, Plemper RK, Finger A, Wolf DH. Der3p/Hrd1p is required for endoplasmic reticulum-associated degradation of misfolded lumenal and integral membrane proteins. Mol Biol Cell. 1998;9(1):209–22. doi: 10.1091/mbc.9.1.209 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Wang M, Kaufman RJ. Protein misfolding in the endoplasmic reticulum as a conduit to human disease. Nature. 2016;529(7586):326–35. doi: 10.1038/nature17041 [DOI] [PubMed] [Google Scholar]
  • 68.Chow CY, Avila FW, Clark AG, Wolfner MF. Induction of excessive endoplasmic reticulum stress in the Drosophila male accessory gland results in infertility. PLoS One. 2015;10(3):e0119386. doi: 10.1371/journal.pone.0119386 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Ryoo HD. Drosophila as a model for unfolded protein response research. BMB Rep. 2015;48(8):445–53. doi: 10.5483/bmbrep.2015.48.8.099 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Kimata Y, Oikawa D, Shimizu Y, Ishiwata-Kimata Y, Kohno K. A role for BiP as an adjustor for the endoplasmic reticulum stress-sensing protein Ire1. J Cell Biol. 2004;167(3):445–56. doi: 10.1083/jcb.200405153 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Owusu-Ansah E, Yavari A, Mandal S, Banerjee U. Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint. Nat Genet. 2008;40(3):356–61. doi: 10.1038/ng.2007.50 [DOI] [PubMed] [Google Scholar]
  • 72.Laker RC, Xu P, Ryall KA, Sujkowski A, Kenwood BM, Chain KH, et al. A novel MitoTimer reporter gene for mitochondrial content, structure, stress, and damage in vivo. J Biol Chem. 2014;289(17):12005–15. doi: 10.1074/jbc.M113.530527 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Ammazzalorso F, Pirzio LM, Bignami M, Franchitto A, Pichierri P. ATR and ATM differently regulate WRN to prevent DSBs at stalled replication forks and promote replication fork recovery. EMBO J. 2010;29(18):3156–69. doi: 10.1038/emboj.2010.205 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Madigan JP, Chotkowski HL, Glaser RL. DNA double-strand break-induced phosphorylation of Drosophila histone variant H2Av helps prevent radiation-induced apoptosis. Nucleic Acids Res. 2002;30(17):3698–705. doi: 10.1093/nar/gkf496 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Park J-S, Lee S-H, Na H-J, Pyo J-H, Kim Y-S, Yoo M-A. Age- and oxidative stress-induced DNA damage in Drosophila intestinal stem cells as marked by Gamma-H2AX. Exp Gerontol. 2012;47(5):401–5. doi: 10.1016/j.exger.2012.02.007 [DOI] [PubMed] [Google Scholar]
  • 76.Tchakarska G, Sola B. The double dealing of cyclin D1. Cell Cycle. 2020;19(2):163–78. doi: 10.1080/15384101.2019.1706903 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Dhillon KK, Sidorova JM, Albertson TM, Anderson JB, Ladiges WC, Rabinovitch PS, et al. Divergent cellular phenotypes of human and mouse cells lacking the Werner syndrome RecQ helicase. DNA Repair (Amst). 2010;9(1):11–22. doi: 10.1016/j.dnarep.2009.09.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Ariyoshi K, Suzuki K, Goto M, Watanabe M, Kodama S. Increased chromosome instability and accumulation of DNA double-strand breaks in Werner syndrome cells. J Radiat Res. 2007;48(3):219–31. doi: 10.1269/jrr.07017 [DOI] [PubMed] [Google Scholar]
  • 79.Kyng KJ, May A, Stevnsner T, Becker KG, Kølvrå S, Bohr VA. Gene expression responses to DNA damage are altered in human aging and in Werner syndrome. Oncogene. 2005;24(32):5026–42. doi: 10.1038/sj.onc.1208692 [DOI] [PubMed] [Google Scholar]
  • 80.Luo J. WRN protein and Werner syndrome. N Am J Med Sci (Boston). 2010;3(4):205–7. doi: 10.7156/v3i4p205 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Poot M, Jin X, Hill JP, Gollahon KA, Rabinovitch PS. Distinct functions for WRN and TP53 in a shared pathway of cellular response to 1-beta-D-arabinofuranosylcytosine and bleomycin. Exp Cell Res. 2004;296(2):327–36. doi: 10.1016/j.yexcr.2004.02.011 [DOI] [PubMed] [Google Scholar]
  • 82.Poot M, Yom JS, Whang SH, Kato JT, Gollahon KA, Rabinovitch PS. Werner syndrome cells are sensitive to DNA cross-linking drugs. FASEB J. 2001;15(7):1224–6. doi: 10.1096/fj.00-0611fje [DOI] [PubMed] [Google Scholar]
  • 83.Kamath-Loeb AS, Zavala-van Rankin DG, Flores-Morales J, Emond MJ, Sidorova JM, Carnevale A, et al. Homozygosity for the WRN helicase-inactivating variant, R834C, does not confer a Werner syndrome clinical phenotype. Sci Rep. 2017;7:44081. doi: 10.1038/srep44081 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.François-Moutal L, Scott DD, Ambrose AJ, Zerio CJ, Rodriguez-Sanchez M, Dissanayake K, et al. Heat shock protein Grp78/BiP/HspA5 binds directly to TDP-43 and mitigates toxicity associated with disease pathology. Sci Rep. 2022;12(1):8140. doi: 10.1038/s41598-022-12191-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Liu Z, Liu G, Ha DP, Wang J, Xiong M, Lee AS. ER chaperone GRP78/BiP translocates to the nucleus under stress and acts as a transcriptional regulator. Proc Natl Acad Sci U S A. 2023;120(31):e2303448120. doi: 10.1073/pnas.2303448120 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Fang EF, Hou Y, Lautrup S, Jensen MB, Yang B, SenGupta T, et al. NAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome. Nat Commun. 2019;10(1):5284. doi: 10.1038/s41467-019-13172-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Gudmundsrud R, Skjånes TH, Gilmour BC, Caponio D, Lautrup S, Fang EF. Crosstalk among DNA damage, mitochondrial dysfunction, impaired mitophagy, stem cell attrition, and senescence in the accelerated ageing disorder Werner syndrome. Cytogenet Genome Res. 2021;161(6–7):297–304. doi: 10.1159/000516386 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Pazhanisamy SK. Stem cells, DNA damage, ageing and cancer. Hematol Oncol Stem Cell Ther. 2009;2(3):375–84. doi: 10.1016/s1658-3876(09)50005-2 [DOI] [PubMed] [Google Scholar]
  • 89.Mani C, Reddy PH, Palle K. DNA repair fidelity in stem cell maintenance, health, and disease. Biochim Biophys Acta Mol Basis Dis. 2020;1866(4):165444. doi: 10.1016/j.bbadis.2019.03.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Wengner AM, Scholz A, Haendler B. Targeting DNA damage response in prostate and breast cancer. Int J Mol Sci. 2020;21(21):8273. doi: 10.3390/ijms21218273 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Baxter JS, Zatreanu D, Pettitt SJ, Lord CJ. Resistance to DNA repair inhibitors in cancer. Mol Oncol. 2022;16(21):3811–27. doi: 10.1002/1878-0261.13224 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Gomollón F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay JO, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: Part 1: diagnosis and medical management. J Crohns Colitis. 2017;11(1):3–25. doi: 10.1093/ecco-jcc/jjw168 [DOI] [PubMed] [Google Scholar]
  • 93.Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, et al. Third european evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017;11(6):649–70. doi: 10.1093/ecco-jcc/jjx008 [DOI] [PubMed] [Google Scholar]
  • 94.Carvalho GB, Ja WW, Benzer S. Non-lethal PCR genotyping of single Drosophila. Biotechniques. 2009;46(4):312–4. doi: 10.2144/000113088 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Chen S, Lyanguzova M, Kaufhold R, Plevock Haase KM, Lee H, Arnaoutov A, et al. Association of RanGAP to nuclear pore complex component, RanBP2/Nup358, is required for pupal development in Drosophila. Cell Rep. 2021;37(13):110151. doi: 10.1016/j.celrep.2021.110151 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Kondo S, Ueda R. Highly improved gene targeting by germline-specific Cas9 expression in Drosophila. Genetics. 2013;195(3):715–21. doi: 10.1534/genetics.113.156737 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Du G, Xiong L, Li X, Zhuo Z, Zhuang X, Yu Z, et al. Peroxisome elevation induces stem cell differentiation and intestinal epithelial repair. Dev Cell. 2020;53(2):169–184.e11. doi: 10.1016/j.devcel.2020.03.002 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Ines Alvarez-Garcia

25 Mar 2024

Dear Dr Chen,

Thank you for submitting your manuscript entitled "Werner syndrome exonuclease promotes gut regeneration but causes ageassociated gut hyperplasia" for consideration as a Research Article by PLOS Biology.

Your manuscript has now been evaluated by the PLOS Biology editorial staff as well as by an academic editor with relevant expertise and I am writing to let you know that we would like to send your submission out for external peer review.

However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire.

Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. After your manuscript has passed the checks it will be sent out for review. To provide the metadata for your submission, please Login to Editorial Manager (https://www.editorialmanager.com/pbiology) within two working days, i.e. by Mar 27 2024 11:59PM.

If your manuscript has been previously peer-reviewed at another journal, PLOS Biology is willing to work with those reviews in order to avoid re-starting the process. Submission of the previous reviews is entirely optional and our ability to use them effectively will depend on the willingness of the previous journal to confirm the content of the reports and share the reviewer identities. Please note that we reserve the right to invite additional reviewers if we consider that additional/independent reviewers are needed, although we aim to avoid this as far as possible. In our experience, working with previous reviews does save time.

If you would like us to consider previous reviewer reports, please edit your cover letter to let us know and include the name of the journal where the work was previously considered and the manuscript ID it was given. In addition, please upload a response to the reviews as a 'Prior Peer Review' file type, which should include the reports in full and a point-by-point reply detailing how you have or plan to address the reviewers' concerns.

During the process of completing your manuscript submission, you will be invited to opt-in to posting your pre-review manuscript as a bioRxiv preprint. Visit http://journals.plos.org/plosbiology/s/preprints for full details. If you consent to posting your current manuscript as a preprint, please upload a single Preprint PDF.

Feel free to email us at plosbiology@plos.org if you have any queries relating to your submission.

Kind regards,

Ines

--

Ines Alvarez-Garcia, PhD

Senior Editor

PLOS Biology

ialvarez-garcia@plos.org

Decision Letter 1

Ines Alvarez-Garcia

16 Jun 2024

Dear Dr Chen,

Thank you for your patience while your manuscript entitled "Werner syndrome exonuclease promotes gut regeneration but causes ageassociated gut hyperplasia" was peer-reviewed at PLOS Biology. Please also accept my apologies for the delay in providing you with our decision. The manuscript has now been evaluated by the PLOS Biology editors, an Academic Editor with relevant expertise, and by three independent reviewers.

The reviews are attached below. As you will see, the reviewers find the conclusions interesting and novel, however they also raise several concerns that would need to be addressed. Reviewer 1 thinks that the functional interaction between Hsc70 and WRN exo should be follow up to strengthen the paper, and also points out that the DNA damage experiments are too superficial and don’t explain causal association, and that the use of colon samples is not relevant to the paper. In addition, this reviewer finds some of the conclusions overstated, and thinks they should be toned down. Reviewer 2 notes that the main experiments are performed with fly lines that are not backcrossed into a common background, and that such backcrossing is essential when looking at aging, as the background could induce false positive. The Academic Editor agrees, thus we would like you to repeat these experiments with backcrossed lines, as suggested by this reviewer. Reviewer 2 also asks for several clarifications regarding the role of Xbp1 activation and ageing, and, along with Reviewer 3, makes several suggestions to improve the experiments, including additional controls and clarifications.

In light of the reviews, we would like to invite you to revise the work to thoroughly address the reviewers' reports. Given the extent of revision needed, we cannot make a decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is likely to be sent for further evaluation by all or a subset of the reviewers.

We expect to receive your revised manuscript within 6 months. Please email us (plosbiology@plos.org) if you have any questions or concerns.

At this stage, your manuscript remains formally under active consideration at our journal; please notify us by email if you do not intend to submit a revision so that we may withdraw it.

**IMPORTANT - SUBMITTING YOUR REVISION**

Your revisions should address the specific points made by each reviewer. Please submit the following files along with your revised manuscript:

1. A 'Response to Reviewers' file - this should detail your responses to the editorial requests, present a point-by-point response to all of the reviewers' comments, and indicate the changes made to the manuscript.

*NOTE: In your point-by-point response to the reviewers, please provide the full context of each review. Do not selectively quote paragraphs or sentences to reply to. The entire set of reviewer comments should be present in full and each specific point should be responded to individually, point by point.

You should also cite any additional relevant literature that has been published since the original submission and mention any additional citations in your response.

2. In addition to a clean copy of the manuscript, please also upload a 'track-changes' version of your manuscript that specifies the edits made. This should be uploaded as a "Revised Article with Changes Highlighted" file type.

3. Resubmission Checklist

When you are ready to resubmit your revised manuscript, please refer to this resubmission checklist: https://plos.io/Biology_Checklist

To submit a revised version of your manuscript, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' where you will find your submission record.

Please make sure to read the following important policies and guidelines while preparing your revision and fulfil the editorial requests:

a) *PLOS Data Policy*

Please note that as a condition of publication PLOS' data policy (http://journals.plos.org/plosbiology/s/data-availability) requires that you make available all data used to draw the conclusions arrived at in your manuscript. If you have not already done so, you must include any data used in your manuscript either in appropriate repositories, within the body of the manuscript, or as supporting information (N.B. this includes any numerical values that were used to generate graphs, histograms etc.). Please also indicate in each figure legend where the data can be found. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5

b) *Published Peer Review*

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/

c) *Blot and Gel Data Policy*

Please provide the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare them now, if you have not already uploaded them. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements

d) *Blurb*

Please also provide a blurb which (if accepted) will be included in our weekly and monthly Electronic Table of Contents, sent out to readers of PLOS Biology, and may be used to promote your article in social media. The blurb should be about 30-40 words long and is subject to editorial changes. It should, without exaggeration, entice people to read your manuscript. It should not be redundant with the title and should not contain acronyms or abbreviations. For examples, view our author guidelines: https://journals.plos.org/plosbiology/s/revising-your-manuscript#loc-blurb

e) *Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods

Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Ines

--

Ines Alvarez-Garcia, PhD

Senior Editor

PLOS Biology

ialvarez-garcia@plos.org

----------------------------------------------

Reviewers' comments

Rev. 1:

It is a worthwhile study to investigate the role of WRN in the aging process in the gut, but this is not as novel as they claim and there has been many studies of WRN expression with aging in humans and model systems.

There are many semantic errors in the text and it has not been proofed for English language.

The work represents an overload of diverse data that represent different aspects and do not all fit together. The quality of the experiments are generally high but too many diverse things are being explored and often not sufficiently in depth.

The observations of an association between Hsc70 and WRN exo (Fig 5) are potentially interesting, and they need to follow that up to determine if there is a functional interaction between these two proteins. If Hsc70 fragments stimulate the exonuclease activity in vitro, it would strongly support their finding.

The DNA damage experiments are somewhat superficial and do not explain causal association. Also they, use UV and claim it induces DNA double strand breaks. That is not the case.

The use of human colon samples is not so relevant here. As they point out, the Drosophila WRN only has Exo activity and is therefore quite different from the human, which also has helicase activity and there are many studies with human WRN implicating it in replication, but mainly via helicase function.

Rev. 2:

In this manuscript, Wu and coworkers examine the role of Werner syndrome exonuclease in natural ageing. This is an interesting topic as the loss-of-function in this exonuclease results in progeria but the role of the protein in normal ageing has not been examined. The authors present data, obtained mostly in Drosophila, to support their model where WRNexo accumulates due to DNA damage in intestinal stem cells (ISCs), modulates the ER unfolded protein response and redox balance in the ISCs and drives intestinal hyperplasia during ageing. In a way, this contrasts to the progeria observed upon loss-of-function of WRN. Overall, the work is interesting and well executed but there are a few aspects of their model that do not appear to fit; I find they do not make sense, at least not to me, and I think they need to be addressed before I can recommend the manuscript for publication in PLoS Biology. These are predominantly to do with the analysis of Xbp1's role:

1. Regarding Xbp1 activation: This is usually assessed by looking at splicing of the 1ry transcript, but the authors look at Xbp1 nuclear localization and in the conditions where Xbp1-EGFP is overexpressed. What is this Xbp1-EGFP construct? Is it reporting splicing? In this case this should be made explicit and consistent throughout the text. Additionally, it would be important to look at the splicing of the native transcript in at least one of their experiments, to avoid any potential artefacts of Xbp1-EGFP overexpression.

2. Regarding the function of Xbp1: It is surprising and inconsistent with the other results presented that Xbp1 knockdown improves proliferation in cells with a loss-of-function of WRNexo. As WRNexo is required and sufficient to induce proliferation and it presumably activates Xbp1, the converse would be expected, that WRNexo over-expression requires Xbp1 to induce proliferation.

3. Regarding Xbp1 and aging: the authors argue for a pro-aging role of WRNexo but this is somewhat inconsistent with the induction of Xbp1 in ISCs being able to promote organismal longevity and reduce the hyperplasia (e.g. Wang et al PLoS Genetics 2015; Li et al iScience 2024).

4. Bip is not only transcriptionally induced by Xbp1, it also regulates Xbp1 splicing (e.g. Kimata et al JCB 2004). This should be made clear throughout the text.

Additionally, I would expect the authors to address they key aspects of the following concerns:

5. The authors present WRNexo as driving aging. They do show that it is required and sufficient for age-related hyperplasia, however, would it not be more appropriate to test if over-expression or knockdown of WRNexo in adult ISC is able to modulate lifespan in a way the authors would expect?

6. It does not appear that any of the fly lines used were backcrossed into a common background. Such backcrossing is essential when looking at aging or age-related phenotypes (e.g. lifespan, pH3+ accumulation in old flies etc.) in the fruit fly as differences in background could introduce false positives (see Partridge and Gems Nature 2007). The key experiments will have to be repeated with backcrossed lines.

7. In several figures, "control" is not clearly defined. It should be defined in the caption (driver alone, or a control RNAi, or simply wild-type flies?).

8. When analyzing data obtained by signal quantification from confocal images, I think it would be important to account for the fact that signal from different cells within one individual will be correlated by using e.g. mixed effects linear models.

Rev. 3:

The authors present a study investigating the function of WRN in regulating ISC proliferation in response to aging. The further findings have significant implications that WRN can bind to Hsc70-3/Bip and regulate UPR. However, addressing the major concerns will strengthen the manuscript. To see specific comments below.

Major concerns:

1. In Figure 2C, the flies used are stated to be 30-day-old, whereas in Figures 2A, 2D, and 2E, the flies used are mentioned to be 45-day-old. To ensure accurate comparisons, it is recommended to use the same age groups for all figures.

2. Figures 2L and 2M lack a control group for comparison.

3. For Fig. 3, Q to T. the expression of WRNexo cDNA by esg-Gal4 rescued the proliferation defect of ISCs in WRNexo-null midguts after injury, but there are no Figs to show proliferation defect in WRNexo-null midguts.

4. The authors suggested that WRNexo contributes to the response to ER stress, therefore it should show that the ER stress can be rescued in response to TM treatment when WRNexo is blocked.

5. The authors hypothesize that the overexpressed WRNexo interacts with Hsc70-3, inhibiting its function and subsequently inducing Xbp1 splicing. However, to further support this hypothesis, additional experiments should be conducted.

6. In the last part of the result, the expression of WRNexo can repress DNA damage, however, the induction of DNA damage corresponded to an upregulation of WRNexo. The authors should provide explanations for supporting the findings.

Minor concerns:

1. The conclusion that "these data indicate that the depletion of WRNexo led to the loss of gut homeostasis upon aging in Drosophila" should be more specific.

2. "Following PQ treatment, ROS levels in esg+ cells of flies with esgts-Gal4-driven WRNexo RNAi expression were significantly lower than in the controls. (Fig. 6, I to K)". The authors should do more work for the similar grammar problems.

Attachment

Submitted filename: PLOS BIOL WRN ext review.docx

pbio.3003121.s023.docx (12.3KB, docx)

Decision Letter 2

Ines Alvarez-Garcia

6 Feb 2025

Dear Dr Chen,

Thank you for your patience while we considered your revised manuscript entitled "Werner syndrome exonuclease promotes gut regeneration but causes age-associated gut hyperplasia" for publication as a Research Article at PLOS Biology. This revised version of your manuscript has been evaluated by the PLOS Biology editors, the Academic Editor and the three original reviewers.

Based on the reviews (attached below), we are likely to accept this manuscript for publication, provided you satisfactorily address the remaining points raised by Reviewer 2. Please also make sure to address the data and other policy-related requests stated below.

In addition, we would like you to consider a suggestion to improve the title:

"Werner syndrome exonuclease promotes gut regeneration and causes age-associated gut hyperplasia in Drosophila"

As you address these items, please take this last chance to review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the cover letter that accompanies your revised manuscript.

We expect to receive your revised manuscript within two weeks.

To submit your revision, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' to find your submission record. Your revised submission must include the following:

- a cover letter that should detail your responses to any editorial requests, if applicable, and whether changes have been made to the reference list

- a Response to Reviewers file that provides a detailed response to the reviewers' comments (if applicable, if not applicable please do not delete your existing 'Response to Reviewers' file.)

- a track-changes file indicating any changes that you have made to the manuscript.

NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines:

https://journals.plos.org/plosbiology/s/supporting-information

*Published Peer Review History*

Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://plos.org/published-peer-review-history/

*Press*

Should you, your institution's press office or the journal office choose to press release your paper, please ensure you have opted out of Early Article Posting on the submission form. We ask that you notify us as soon as possible if you or your institution is planning to press release the article.

*Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please do not hesitate to contact me should you have any questions.

Sincerely,

Ines

--

Ines Alvarez-Garcia, PhD

Senior Editor

PLOS Biology

ialvarez-garcia@plos.org

------------------------------------------------------------------------

DATA POLICY: IMPORTANT - PLEASE READ

You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: http://journals.plos.org/plosbiology/s/data-availability. For more information, please also see this editorial: http://dx.doi.org/10.1371/journal.pbio.1001797

Note that we do not require all raw data. Rather, we ask that all individual quantitative observations that underlie the data summarized in the figures and results of your paper be made available in one of the following forms:

1) Supplementary files (e.g., excel). Please ensure that all data files are uploaded as 'Supporting Information' and are invariably referred to (in the manuscript, figure legends, and the Description field when uploading your files) using the following format verbatim: S1 Data, S2 Data, etc. Multiple panels of a single or even several figures can be included as multiple sheets in one excel file that is saved using exactly the following convention: S1_Data.xlsx (using an underscore).

2) Deposition in a publicly available repository. Please also provide the accession code or a reviewer link so that we may view your data before publication.

Regardless of the method selected, please ensure that you provide the individual numerical values that underlie the summary data displayed in the following figure panels as they are essential for readers to assess your analysis and to reproduce it:

Fig. 1C, E, F, I, J, L, M, P, Q, Z, A’, B’; Fig. 2A, H, I, J, M, Q, R, T, X, A’; Fig. 3A-D, T; Fig. 4A, B, F, J, G; Fig. 5K, P, U; Fig. 6C-F, I, K, O, R, W, X; Fig. 7C, D, G, H, M, N; Fig. S1E, F, H, I, J; Fig. S2F, J, K, O; Fig. S4A, B; Fig. S5E, H; Fig. S6B, D, H, M, Q and Fig. S7D, H

NOTE: the numerical data provided should include all replicates AND the way in which the plotted mean and errors were derived (it should not present only the mean/average values).

Please also ensure that figure legends in your manuscript include information on WHERE THE UNDERLYING DATA CAN BE FOUND, and ensure your supplemental data file/s has a legend.

Please ensure that your Data Statement in the submission system accurately describes where your data can be found.

------------------------------------------------------------------------

CODE POLICY

Per journal policy, if you have generated any custom code during the course of this investigation, please make it available without restrictions. Please ensure that the code is sufficiently well documented and reusable, and that your Data Statement in the Editorial Manager submission system accurately describes where your code can be found.

Please note that we cannot accept sole deposition of code in GitHub, as this could be changed after publication. However, you can archive this version of your publicly available GitHub code to Zenodo. Once you do this, it will generate a DOI number, which you will need to provide in the Data Accessibility Statement (you are welcome to also provide the GitHub access information). See the process for doing this here: https://docs.github.com/en/repositories/archiving-a-github-repository/referencing-and-citing-content

------------------------------------------------------------------------

BLOT AND GEL REPORTING REQUIREMENTS:

We require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. Please provide the raw gels shown in the following figures:

Fig. 1K; Fig. 5D, E and Fig. 6J

We will require these files before a manuscript can be accepted so please prepare and upload them now. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements

------------------------------------------------------------------------

Reviewers' comments

Rev. 1: Vilhelm Bohr - note that his reviewer has signed his review.

I think they have adequately responded to the reviewers concerns and that the MS should be acceptable.

Rev. 2:

I thank the authors for taking my comments on board. I think most have been addressed sufficiently well but there are two where I would appreciate the authors make small additional changes in the text.

Regarding my original comment (1) about the Xbp1 GFP reporter, it is clear even from the diagram provided by the authors in the rebuttal that this construct is reporting the splicing of Xbp1 and not simply its nuclear localisation. It would be good if the authors would make this clear on page 13. The qPCR shown in the rebuttal should also be shown in the manuscript (e.g. in a supplementary figure).

Regarding my comment (6) about backcrossing: thank you for clarifying. However, I find that the information in the methods is still not sufficient. Please explicitly note which lines were backcrossed or write that all lines used in the manuscript were backcrossed, and provide information about how the unmarked mutants/constructs were backcrossed (I believe the Crispr mutants were not marked, apologies if I have misunderstood).

Additional minor suggested changes:

Page 2, end of the abstract: "elevated WNRexo-mediated mechanism" - the expression is a bit clumsy - please change for clarity.

Page 6, start of the results: "contrary to our prediction" - please explain the prediction and reasoning for clarity.

Page 11, section title: "via regulate" - by regulating?

Page 12: Hsp70Ba, Hsp70Bb, Hsp68, Hsp67Ba and Hsp67Bc are referred to as UPR-ER genes - please provide a reference for this. If they are not UPR-ER genes (as I belive they are not ER chaperones), it may be advisable to refer to them as "involved in proteostasis" or something similarly broad.

Page 14, top of the page: "Xbp1 encodes a … signalling," - this is somewhat redundant.

Rev. 3: Aiguo Tian - note that this reviewer has signed his review.

My concerns have been addressed.

Decision Letter 3

Ines Alvarez-Garcia

18 Mar 2025

Dear Dr Chen,

Thank you for the submission of your revised Research Article entitled "Werner syndrome exonuclease promotes gut regeneration and causes age-associated gut hyperplasia in Drosophila" for publication in PLOS Biology. On behalf of my colleagues and the Academic Editor, Alex Gould, I am delighted to let you know that we can in principle accept your manuscript for publication, provided you address any remaining formatting and reporting issues. These will be detailed in an email you should receive within 2-3 business days from our colleagues in the journal operations team; no action is required from you until then. Please note that we will not be able to formally accept your manuscript and schedule it for publication until you have completed any requested changes.

Please take a minute to log into Editorial Manager at http://www.editorialmanager.com/pbiology/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production process.

PRESS

We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with biologypress@plos.org. If you have previously opted in to the early version process, we ask that you notify us immediately of any press plans so that we may opt out on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/.

Many congratulations and thanks again for choosing PLOS Biology for publication and supporting Open Access publishing. We look forward to publishing your study. 

Sincerely, 

Ines

--

Ines Alvarez-Garcia, PhD

Senior Editor

PLOS Biology

ialvarez-garcia@plos.org

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. WRNexo is expressed in Drosophila midguts and the expression increases with aging, related to Fig 1.

    Underlying data and statistical analysis in S1 Data.

    (DOCX)

    pbio.3003121.s001.docx (1.4MB, docx)
    S2 Fig. WRNexo is essential for gut homeostasis, related to Fig 2.

    Underlying data and statistical analysis in S2 Data.

    (DOCX)

    pbio.3003121.s002.docx (916.7KB, docx)
    S3 Fig. WRNexo functions cell-autonomously in ISCs to promote ISC proliferation, related to Fig 3.

    (DOCX)

    pbio.3003121.s003.docx (1.2MB, docx)
    S4 Fig. WRNexo protein directly interacts with protein Hsc70-3/Bip, related to Figs 4 and 5.

    Underlying data and statistical analysis in S4 Data.

    (DOCX)

    pbio.3003121.s004.docx (501.6KB, docx)
    S5 Fig. WRNexo regulates the cellular redox state and modulates ISC proliferation by UPRER pathway, related to Fig 6.

    Underlying data and statistical analysis in S6 Data.

    (DOCX)

    pbio.3003121.s005.docx (937.3KB, docx)
    S6 Fig. WRNexo regulates ISC proliferation by Hsc70−3 and JNK signaling, related to Fig 6.

    Underlying data and statistical analysis in S6 Data.

    (DOCX)

    pbio.3003121.s006.docx (1.3MB, docx)
    S7 Fig. DNA double strands break induces WRNexo expression, related to Fig 7.

    Underlying data and statistical analysis in S7 Data.

    (DOCX)

    pbio.3003121.s007.docx (1.3MB, docx)
    S1 Table. List of gene counts from RNA-seq without BLM injury (WT and WRNexo-null), normalized by the DESeq2 R package, related to Fig 4.

    Gene symbols are indicated.

    (XLSX)

    pbio.3003121.s008.xlsx (1,003.2KB, xlsx)
    S2 Table. List of gene counts from RNA-seq with BLM injury (WT and WRNexo-null), normalized by the DESeq2 R package, related to Fig 4.

    Gene symbols are indicated.

    (XLSX)

    S3 Table. Full Drosophila genotypes as they appear in each figure panel, related to Figs 17 and S1S7.

    (XLSX)

    pbio.3003121.s010.xlsx (13.9KB, xlsx)
    S4 Table. Initial mass spectrometry (MASS) analysis was performed on nuclear proteins extracted from the midguts of flies carrying an esgts-GAL4-driven UAS-WRNexo-3xHA.

    (XLSX)

    pbio.3003121.s011.xlsx (25.2KB, xlsx)
    S5 Table. The second mass spectrometry (MASS) analysis of nuclear proteins extracted from the midguts of flies with esgts-GAL4-driven UAS-WRNexo-3xHA was performed.

    (XLSX)

    pbio.3003121.s012.xlsx (32.9KB, xlsx)
    S6 Table. The third mass spectrometry (MASS) analysis was performed on nuclear proteins extracted from the midguts of flies carrying an esgts-GAL4-driven UAS-WRNexo-3xHA.

    (XLSX)

    pbio.3003121.s013.xlsx (16.4KB, xlsx)
    S1 Data. Underlying data for Figs 1 and S1.

    (XLSX)

    pbio.3003121.s014.xlsx (34.1KB, xlsx)
    S2 Data. Underlying data for Figs 2 and S2.

    (XLSX)

    pbio.3003121.s015.xlsx (35.4KB, xlsx)
    S3 Data. Underlying data for Fig 3.

    (XLSX)

    pbio.3003121.s016.xlsx (20.4KB, xlsx)
    S4 Data. Underlying data for Figs 4 and S4.

    (XLSX)

    pbio.3003121.s017.xlsx (18.4KB, xlsx)
    S5 Data. Underlying data for Fig 5.

    (XLSX)

    pbio.3003121.s018.xlsx (11.9KB, xlsx)
    S6 Data. Underlying data for Figs 6, S5, and S6.

    (XLSX)

    pbio.3003121.s019.xlsx (32.3KB, xlsx)
    S7 Data. Underlying data for Figs 7 and S7.

    (XLSX)

    pbio.3003121.s020.xlsx (23KB, xlsx)
    S1 Raw Images. Raw Images for Figs 1D, 1K, 5D, 5E, and 6J.

    (PDF)

    pbio.3003121.s021.pdf (1.8MB, pdf)
    Attachment

    Submitted filename: PLOS BIOL WRN ext review.docx

    pbio.3003121.s023.docx (12.3KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pbio.3003121.s025.docx (13.9MB, docx)
    Attachment

    Submitted filename: Response Letter to Reviewers.docx

    pbio.3003121.s026.docx (29KB, docx)

    Data Availability Statement

    All data presented are available in the main text or the supplementary materials. The RNA-seq data supporting this study have been deposited in PRJNA944585 (Fig 4A, 4B), with source data provided in S1 and S2 Tables.


    Articles from PLOS Biology are provided here courtesy of PLOS

    RESOURCES